Carter Validus Mission Critical REIT 10-Q 14 May 15 2015 Q1 Quarterly report Financial data

Document_And_Entity_Informatio

Document And Entity Information	3 Months Ended
	Mar. 31, 2015	11-May-15
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	FALSE
Document Period End Date	31-Mar-15
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q1
Entity Registrant Name	Carter Validus Mission Critical REIT, Inc.
Entity Central Index Key	1482974
Current Fiscal Year End Date	-19
Entity Filer Category	Non-accelerated Filer
Entity Common Stock, Shares Outstanding		177,768,000

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Real estate:
Land ($4,280 and $4,280 related to VIE)	$163,908	$153,998
Buildings and improvements, less accumulated depreciation of $64,072 and $52,779, respectively ($87,206 and $87,850 related to VIE)	1,676,483	1,584,726
Construction in process	65,119	53,552
Acquired intangible assets, less accumulated amortization of $26,327 and $21,765, respectively ($10,901 and $11,314 related to VIE)	208,003	204,511
Total real estate, net ($102,387 and $103,444 related to VIE)	2,113,513	1,996,787
Cash and cash equivalents ($2,457 and $1,397 related to VIE)	74,542	113,093
Real estate-related notes receivables	10,014	23,535
Preferred equity investment	101,637	0
Other assets ($5,212 and $5,126 related to VIE)	63,344	57,427
Total assets	2,363,050	2,190,842
Liabilities:
Notes payable ($52,834 and $53,031 related to VIE)	525,202	490,909
Credit facility	225,000	75,000
Accounts payable due to affiliates ($24 and $17 related to VIE)	1,894	1,833
Accounts payable and other liabilities ($1,346 and $1,473 related to VIE)	34,439	31,829
Intangible lease liabilities, less accumulated amortization of $12,598 and $10,774, respectively ($13,954 and $14,445 related to VIE)	58,854	60,678
Total liabilities	845,389	660,249
Stockholders' equity:
Preferred stock, $0.01 par value per share, 50,000,000 shares authorized; none issued and outstanding
Common stock, $0.01 par value per share, 300,000,000 shares authorized; 177,310,055 and 175,561,681 shares issued, respectively; 176,653,515 and 175,038,055 shares outstanding, respectively	1,767	1,750
Additional paid-in capital	1,572,939	1,557,623
Accumulated distributions in excess of earnings	-118,662	-100,273
Accumulated other comprehensive loss	-3,133	-1,161
Total stockholders' equity	1,452,911	1,457,939
Noncontrolling interests	64,750	72,654
Total equity	1,517,661	1,530,593
Total liabilities and stockholders' equity	$2,363,050	$2,190,842

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Parenthetical) (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, except Share data, unless otherwise specified
Land	$163,908	$153,998
Buildings and improvements, accumulated depreciation	64,072	52,779
Buildings and improvements, net	1,676,483	1,584,726
Acquired intangible assets, accumulated amortization	26,327	21,765
Acquired intangible assets, net	208,003	204,511
Total real estate, net	2,113,513	1,996,787
Cash and cash equivalents	74,542	113,093
Other assets	63,344	57,427
Notes payable	525,202	490,909
Accounts payable due to affiliates	1,894	1,833
Accounts payable and other liabilities	34,439	31,829
Intangible lease liabilities, accumulated amortization	12,598	10,774
Intangible lease liabilities, net	58,854	60,678
Preferred stock, par value	$0.01	$0.01
Preferred stock, shares authorized	50,000,000	50,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$0.01	$0.01
Common stock, shares authorized	300,000,000	300,000,000
Common stock, shares issued	177,310,055	175,561,681
Common stock, shares outstanding	176,653,515	175,038,055
Variable Interest Entity, Primary Beneficiary [Member]
Land	4,280	4,280
Buildings and improvements, net	87,206	87,850
Acquired intangible assets, net	10,901	11,314
Total real estate, net	102,387	103,444
Cash and cash equivalents	2,457	1,397
Other assets	5,212	5,126
Notes payable	52,834	53,031
Accounts payable due to affiliates	24	17
Accounts payable and other liabilities	1,346	1,473
Intangible lease liabilities, net	$13,954	$14,445

Condensed_Consolidated_Stateme

Condensed Consolidated Statements Of Comprehensive Income (USD $)	3 Months Ended
In Thousands, except Share data, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Revenue:
Rental and parking revenue	$46,894	$23,410
Tenant reimbursement revenue	4,489	2,742
Real estate-related notes receivables interest income	139	1,151
Total revenue	51,522	27,303
Expenses:
Rental and parking expenses	7,584	3,741
General and administrative expenses	1,409	922
Change in fair value of contingent consideration	150	0
Acquisition related expenses	3,145	1,225
Asset management fees	4,033	2,366
Depreciation and amortization	15,783	8,267
Total expenses	32,104	16,521
Income from operations	19,418	10,782
Other income (expense):
Other income	516	38
Interest expense	-6,306	-4,189
Total other expense	-5,790	-4,151
Net income	13,628	6,631
Net income attributable to noncontrolling interests in consolidated partnerships	-1,614	-645
Net income attributable to common stockholders	12,014	5,986
Other comprehensive income (loss):
Unrealized loss on interest rate swaps, net	-2,212	-238
Other comprehensive loss	-2,212	-238
Other comprehensive loss attributable to noncontrolling interests in consolidated partnerships	240	0
Other comprehensive loss attributable to common stockholders	-1,972	-238
Comprehensive income	11,416	6,393
Comprehensive income attributable to noncontrolling interests in consolidated partnerships	-1,374	-645
Comprehensive income attributable to common stockholders	$10,042	$5,748
Weighted average number of common shares outstanding:
Basic	176,117,122	86,518,155
Diluted	176,133,630	86,535,291
Net income per common share attributable to common stockholders:
Basic	$0.07	$0.07
Diluted	$0.07	$0.07
Distributions declared per common share	$0.17	$0.17

Condensed_Consolidated_Stateme1

Condensed Consolidated Statement Of Stockholders' Equity (USD $)	Parent [Member]	Common Stock [Member]	Additional Paid in Capital [Member]	Accumulated Distributions in Excess of Earnings [Member]	Accumulated Other Comprehensive Loss [Member]	Noncontrolling Interests [Member]	Total
Balance, at Dec. 31, 2014	$1,457,939,000	$1,750,000	$1,557,623,000	($100,273,000)	($1,161,000)	$72,654,000	$1,530,593,000
Balance, shares at Dec. 31, 2014		175,038,055					175,038,055
Vesting of restricted stock, shares		1,500
Issuance of common stock under the distribution reinvestment plan, shares		1,746,875
Issuance of common stock under the distribution reinvestment plan	16,594,000	18,000	16,576,000				16,594,000
Purchase of noncontrolling interests						-8,800,000	-8,800,000
Distributions to noncontrolling interests						-478,000	-478,000
Distributions declared to common stockholders	-30,403,000			-30,403,000			-30,403,000
Redemption of common stock, shares		-132,915
Redemption of common stock	-1,287,000	-1,000	-1,286,000				-1,287,000
Stock-based compensation	26,000		26,000				26,000
Other comprehensive loss	-1,972,000				-1,972,000	-240,000	-2,212,000
Net income	12,014,000			12,014,000		1,614,000	13,628,000
Balance, at Mar. 31, 2015	$1,452,911,000	$1,767,000	$1,572,939,000	($118,662,000)	($3,133,000)	$64,750,000	$1,517,661,000
Balance, shares at Mar. 31, 2015		176,653,515					176,653,515

Condensed_Consolidated_Stateme2

Condensed Consolidated Statements Of Cash Flows (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Cash flows from operating activities:
Net income	$13,628	$6,631
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	15,783	8,267
Amortization of deferred financing costs	898	530
Amortization of above-market leases	90	40
Amortization of intangible lease liabilities	-1,824	-1,003
Amortization of real estate-related notes receivables origination costs and commitment fees	114	353
Straight-line rent	-5,767	-2,714
Stock-based compensation	26	21
Change in fair value of contingent consideration	150	0
Changes in operating assets and liabilities:
Accounts payable and other liabilities	497	-30
Accounts payable due to affiliates	61	2,238
Other assets	360	-1,017
Net cash provided by operating activities	24,016	13,316
Cash flows from investing activities:
Investment in real estate	-107,294	-123,190
Development expenditures	-12,825	-44
Real estate deposits	-290	-557
Real estate-related notes receivables advances	-267	-4,111
Preferred equity investment	-101,637	0
Origination costs net of commitment fees related to real estate-related notes receivables	0	-82
Net cash used in investing activities	-222,313	-127,984
Cash flows from financing activities:
Proceeds from notes payable	37,000	91,466
Payments on notes payable	-2,707	-1,045
Proceeds from credit facility	150,000	0
Payments on credit facility	0	-97,000
Payments of deferred financing costs	-26	-1,838
Repurchase of common stock	-1,287	-597
Offering costs on issuance of common stock	0	-30,755
Distributions to stockholders	-13,714	-6,716
Proceeds from issuance of common stock	0	305,308
Payments to escrow funds	-601	-390
Collections of escrow funds	359	855
Purchase of noncontrolling interest in consolidated partnerships	-8,800	0
Distributions to noncontrolling interests in consolidated partnerships	-478	-561
Net cash provided by financing activities	159,746	258,727
Net change in cash and cash equivalents	-38,551	144,059
Cash and cash equivalents - Beginning of period	113,093	7,511
Cash and cash equivalents - End of period	74,542	151,570
Supplemental cash flow disclosure:
Interest paid, net of interest capitalized of $1,049 and $0, respectively	6,342	3,285
Supplemental disclosure of non-cash transactions:
Common stock issued through distribution reinvestment plan	16,594	6,527
Net unrealized loss on interest rate swap	-2,212	-238
Real estate-related notes receivables converted to investment in real estate	$13,674	$20,000

Condensed_Consolidated_Stateme3

Condensed Consolidated Statements Of Cash Flows (Parenthetical) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Condensed Consolidated Statements Of Cash Flows [Abstract]
Interest capitalized	$1,049	$0

Organization_and_Business_Oper

Organization and Business Operations	3 Months Ended
	Mar. 31, 2015
Organization and Business Operations [Abstract]
Organization and Business Operations	Note 1—Organization and Business Operations
	Carter Validus Mission Critical REIT, Inc., or the Company, a Maryland corporation, was incorporated on December 16, 2009 and currently is treated and qualifies as a real estate investment trust, or a REIT, under the Internal Revenue Code of 1986, as amended, for federal income tax purposes. The Company was organized to acquire and operate a diversified portfolio of income producing commercial real estate, with a focus on the data center and healthcare property sectors, net leased to investment grade and other creditworthy tenants, as well as to make other real estate-related investments that relate to such property types. The Company operates through two reportable segments – commercial real estate investments in data centers and healthcare. Substantially all of the Company’s business is conducted through Carter/Validus Operating Partnership, LP, a Delaware limited partnership, or the Operating Partnership. The Company is the sole general partner of the Operating Partnership. Carter/Validus Advisors, LLC, or the Advisor, the Company’s affiliated advisor, is the sole limited partner of the Operating Partnership.
	As of March 31, 2015, the Company owned 48 real estate investments (including two real estate investments owned through consolidated partnerships), consisting of 77 properties located in 43 metropolitan statistical areas, or MSAs. As of March 31, 2015, the Company had investments in real estate-related notes receivables in the aggregate principal amount of $10,014,000 and the Company had investments in 7.875% Series B Redeemable Cumulative Preferred Stock with a $0.01 par value per share in a private real estate corporation, or the Preferred Equity Investment, in an aggregate amount of $101,637,000.
	The Company ceased offering shares of common stock in its $1,746,875,000 initial public offering, or the Offering, on June 6, 2014. At the completion of the Offering, the Company raised gross proceeds of approximately $1,716,046,000 (including shares of common stock issued pursuant to a distribution reinvestment plan, or the DRIP). The Company will continue to issue shares of common stock under the DRIP Offering (as defined below) until such time as the Company sells all of the shares registered for sale under the DRIP Offering, unless the Company files a new registration statement with the Securities and Exchange Commission, or the SEC, or the DRIP Offering is terminated by the Company’s board of directors.
	In addition, the Company registered $100,000,000 in shares of common stock under the DRIP pursuant to a registration statement on Form S-3 (Registration No. 333-195258), or the DRIP Offering, and collectively with the Offering, the Offerings, which was filed with the SEC on April 14, 2014 and automatically became effective with the SEC upon filing. As of March 31, 2015, the Company had issued approximately 177,271,000 shares of common stock in the Offerings for gross proceeds of $1,760,455,000, before share redemptions of $6,353,000 and offering costs, selling commissions and dealer manager fees of $174,626,000.
	Except as the context otherwise requires, “we,” “our,” “us,” and the “Company” refer to Carter Validus Mission Critical REIT, Inc., the Operating Partnership, all majority-owned subsidiaries and controlled subsidiaries.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2015
Summary of Significant Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2—Summary of Significant Accounting Policies
	The summary of significant accounting policies presented below is designed to assist in understanding the Company’s condensed consolidated financial statements. Such condensed consolidated financial statements and the accompanying notes thereto are the representation of management. The accompanying condensed consolidated unaudited financial statements of the Company have been prepared in accordance with the generally accepted accounting principles in the United States, or GAAP, for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all adjustments, consisting of normal and recurring nature considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2015 are not necessarily indicative of the results that may be expected for the year ending December 31, 2015.
	The condensed consolidated balance sheet at December 31, 2014 has been derived from the audited consolidated financial statements at that date but does not include all of the information and notes required by GAAP for complete financial statements. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with the Company’s audited consolidated financial statements as of and for the year ended December 31, 2014 and related notes thereto set forth in the Company’s Annual Report on Form 10-K, filed with the SEC on March 26, 2015.
	Principles of Consolidation and Basis of Presentation
	The accompanying condensed consolidated financial statements include the accounts of the Company, the Operating Partnership, all majority-owned subsidiaries and controlled subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.
	Use of Estimates
	The preparation of the financial statements in conformity with GAAP necessarily requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
	Concentration of Credit Risk and Significant Leases
	As of March 31, 2015, the Company had cash on deposit, including restricted cash, in several financial institutions which had deposits in excess of current federally insured levels totaling $86.8 million; however, the Company has not experienced any losses in such accounts. The Company limits its cash investments to financial institutions with high credit standings; therefore, the Company believes it is not exposed to any significant credit risk on its cash deposits. To date, the Company has experienced no loss or lack of access to cash in its accounts. Concentration of credit risk with respect to accounts receivable from tenants is limited.
	As of March 31, 2015, the Company owned real estate investments in 43 MSAs, (including two real estate investments owned through consolidated partnerships), four of which accounted for 10.0% or more of rental revenue. Real estate investments located in the Dallas-Ft. Worth-Arlington, Texas MSA, the Chicago-Naperville-Elgin, Illinois-Indiana-Wisconsin MSA, the Atlanta-Sandy Springs-Roswell, Georgia MSA and the Houston-The Woodlands-Sugar Land, Texas MSA accounted for an aggregate of 14.1%, 12.3%,  10.4% and 10.9%, respectively, of rental revenue for the three months ended March 31, 2015.
	As of March 31, 2015, the Company had two tenants that accounted for 10.0% or more of rental revenue. The leases with AT&T Services, Inc. and the lease with Bay Area Regional Medical Center, LLC accounted for 13.6% and 10.7%, respectively, of rental revenue for the three months ended March 31, 2015.
	Share Repurchase Program
	The Company’s share repurchase program allows for repurchases of shares of the Company’s common stock when certain criteria are met. The share repurchase program provides that all redemptions during any calendar year, including those upon death or a qualifying disability of a stockholder, are limited to those that can be funded with proceeds raised from the DRIP Offering.
	Repurchases of shares of the Company’s common stock are at the sole discretion of the Company’s board of directors. In addition, the Company’s board of directors, at its sole discretion, may amend, suspend, reduce, terminate or otherwise change the share repurchase program upon 30 days prior notice to the Company’s stockholders for any reason it deems appropriate. During the three months ended March 31, 2015, the Company received valid redemption requests related to approximately 133,000 shares of common stock, all of which were redeemed in full for an aggregate purchase price of approximately $1,287,000 (an average of $9.68 per share).  During the three months ended March 31, 2014, the Company received valid redemption requests related to approximately 62,000 shares of common stock, all of which were redeemed in full for an aggregate purchase price of approximately $597,000 (an average of $9.63 per share).
	Earnings Per Share
	Basic earnings per share attributable for all periods presented are computed by dividing net income attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period. Shares of non-vested restricted common stock give rise to potentially dilutive shares of common stock. Diluted earnings per share are computed based on the weighted average number of shares outstanding and all potentially dilutive securities. For the three months ended March 31, 2015 and 2014, diluted earnings per share reflect the effect of approximately 17,000 of non-vested shares of restricted common stock that were outstanding as of such period.
	Preferred Equity Investment
	The Company accounts for its Preferred Equity Investment as an asset under the cost method of accounting, as the Company exercises no influence over the investee. The Company recognizes dividends as other income in the condensed consolidated statements of comprehensive income.
	Recently Issued Accounting Pronouncements
	On May 28, 2014, the Financial Accounting Standards Board, or the FASB, issued Accounting Standards Update, or ASU, 2014-09, Revenue from Contracts with Customers, or ASU 2014-09. The objective of ASU 2014-09 is to clarify the principles for recognizing revenue and to develop a common revenue standard for GAAP. The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods and services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. ASU 2014-09 defines a five-step process to achieve this core principle, which may require more judgment and estimates within the revenue recognition process than are required under existing GAAP. The adoption of ASU 2014-09 is effective retrospectively for reporting periods beginning after December 15, 2016. Early adoption of ASU 2014-09 is not permitted. The Company is in the process of evaluating the impact ASU 2014-09 will have on the Company’s condensed consolidated financial statements.
	On February 18, 2015, the FASB issued ASU 2015-02, Consolidation (Topic 810): Amendments to the Consolidation Analysis, or ASU 2015-02, that changes the analysis that a reporting entity must perform to determine whether it should consolidate certain types of legal entities. The amendment affects the following areas: limited partnerships and similar legal entities, evaluating fees paid to a decision maker or a service provider as a variable interest, the effect of fee arrangements on the primary beneficiary determination and certain investment funds. Under the amendment, all reporting entities are within the scope of Subtopic 810-10, Consolidation- Overall, unless a scope exception applies. The presumption that a general partner controls a limited partnership has been eliminated. In addition, fees paid to decision makers that meet certain conditions no longer cause decision makers to consolidate variable interest entities in certain instances. The amendment is effective for public business entities for periods beginning after December 15, 2015. Early adoption of ASU 2015-02 is permitted. The Company is in process of evaluating the impact ASU 2015-02 will have in the Company’s condensed consolidated financial statements.
	On April 7, 2015, the FASB issued ASU 2015-03, Interest- Imputation of Interest, or ASU 2015-03, that intends to simplify the presentation of debt issuance costs. The amendment requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability. The amendment is effective for public business entities for periods beginning after December 15, 2015. The Company is in process of evaluating the impact ASU 2015-03 will have in the Company’s condensed consolidated financial statements.
	Reclassifications
	Certain prior period amounts have been reclassified to conform to the current financial statement presentation, with no effect on the Company’s condensed consolidated financial position or results of operations.

Real_Estate_Investments

Real Estate Investments	3 Months Ended
	Mar. 31, 2015
Real Estate Investments [Abstract]
Real Estate Investments	Note 3—Real Estate Investments
	During the three months ended March 31, 2015, the Company completed the acquisition of two healthcare real estate investment properties, which were determined to be business combinations, for an aggregate purchase price of $120,968,000, plus closing costs, or the 2015 Acquisitions. The aggregate purchase price was settled net of the outstanding balance of real estate-related notes receivables due to the Company of $13,674,000, which reduced the total cash paid to $107,294,000. The Company funded the purchase price of the 2015 Acquisitions using net cash proceeds from the Offerings and its unsecured credit facility. The following table summarizes the 2015 Acquisitions:
			Date		Ownership
	Property Description		Acquired		Percentage
	Landmark Hospital of Savannah		1/15/15		100%
	21st Century Oncology Portfolio		3/31/15		100%
	Results of operations for the 2015 Acquisitions are reflected in the accompanying condensed consolidated statements of comprehensive income for the three months ended March 31, 2015 for the period subsequent to the acquisition date of each property. For the period from the acquisition date through March 31, 2015, the Company recognized $508,000 of revenues and a net loss of $2,706,000 for the 2015 Acquisitions. In addition, during the three months ended March 31, 2015, the Company incurred aggregate charges related to acquisition fees and costs of $2,929,000 in connection with the 2015 Acquisitions, which are included in the accompanying condensed consolidated statements of comprehensive income. The total amount of all acquisition fees and expenses are limited to 6.0% of the contract purchase price of the property. The contract purchase price is the amount actually paid or allocated in respect of the purchase, development, construction or improvement of a property, exclusive of acquisition fees and acquisition expenses. For the three months ended March 31, 2015 and 2014, acquisition fees and expenses did not exceed 6.0% of the purchase price of the Company’s acquisitions during such periods.
	The Company is currently in the process of finalizing the allocation of the fair value purchase price of the 2015 Acquisitions; therefore, these allocations are preliminary and subject to change. The following table summarizes the Company’s preliminary allocation of the fair value purchase price of the 2015 Acquisitions acquired during the three months ended March 31, 2015 (amounts in thousands):
		Total
	Land	$	9,910
	Buildings and improvements		103,004
	In-place leases		8,054
	Total assets acquired	$	120,968
	Assuming the 2015 Acquisitions described above had occurred on January 1, 2014, pro forma revenues, net income and net income attributable to common stockholders would have been as follows (amounts in thousands, unaudited):
			Three Months Ended
			March 31,
			2015			2014
	Pro forma basis:
	Revenues		$	53,640		$	39,662
	Net income		$	17,623		$	12,346
	Net income attributable to common stockholders		$	16,009		$	11,701
	Net income per common share attributable to common
	stockholders:
	Basic		$	0.09		$	0.08
	Diluted		$	0.09		$	0.08
	The pro forma information for the three months ended March 31, 2015 was adjusted to exclude $2,929,000 of acquisition expenses recorded during such periods. The pro forma information is presented for informational purposes only and may not be indicative of what actual results of operations would have been had the transactions occurred at the beginning of 2014, nor is it necessarily indicative of future operating results.

Acquired_Intangible_Assets_Net

Acquired Intangible Assets, Net	3 Months Ended
	Mar. 31, 2015
Acquired Intangible Assets, Net [Abstract]
Acquired Intangible Assets, Net	Note 4—Acquired Intangible Assets, Net
	Acquired intangible assets, net, which are included in real estate in the accompanying condensed consolidated balance sheets, consisted of the following as of March 31, 2015 and December 31, 2014 (amounts in thousands, except weighted average life amounts):
		31-Mar-15		31-Dec-14
	In-place leases, net of accumulated amortization of $25,564 and $21,105, respectively (with a weighted average remaining life of 14.9 years and 15.1 years, respectively)	$	202,306	$	198,710
	Above-market leases, net of accumulated amortization of $619 and $529, respectively (with a weighted average remaining life of 11.2 years and 11.4 years, respectively)		3,027		3,118
	Ground lease interest, net of accumulated amortization of $144 and $131, respectively (with a weighted average remaining life of 61.0 years and 61.2 years, respectively)		2,670		2,683
		$	208,003	$	204,511
	The aggregate weighted average remaining life of the acquired intangible assets was 15.5 years and 15.6 years as of March 31, 2015 and December 31, 2014, respectively.

Other_Assets

Other Assets	3 Months Ended
	Mar. 31, 2015
Other Assets [Abstract]
Other Assets	Note 5—Other Assets
	Other assets consisted of the following as of March 31, 2015 and December 31, 2014  (amounts in thousands):
		31-Mar-15		31-Dec-14
	Deferred financing costs, net of accumulated amortization of $5,430
	and $4,532, respectively	$	10,299	$	11,172
	Lease commissions, net of accumulated amortization of $70
	and $54, respectively		629		394
	Investments in unconsolidated partnerships		104		106
	Tenant receivable, net of allowances for doubtful accounts of $578
	and $0, respectively		2,619		3,361
	Straight-line rent receivable		31,333		25,566
	Restricted cash held in escrow		13,625		13,382
	Real estate escrow deposits		421		250
	Restricted cash		949		734
	Derivative assets		47		273
	Prepaid and other assets, net of allowances for doubtful accounts of $903
	and $0, respectively		3,318		2,189
		$	63,344	$	57,427

Real_EstateRelated_Notes_Recei

Real Estate-Related Notes Receivables	3 Months Ended
	Mar. 31, 2015
Real Estate-Related Notes Receivables [Abstract]
Real Estate-Related Notes Receivables	Note 6—Real Estate-Related Notes Receivables
	As of March 31, 2015, the Company had investments in two real estate-related notes receivables, which are loans made that the Company intends to hold to maturity. Accordingly, real estate-related notes receivables are recorded at stated principal amounts net of any discount or premium and deferred loan origination costs or fees. The related discounts or premiums are accreted or amortized over the life of the real estate-related notes receivables, as applicable. The Company defers certain loan origination and commitment fees and amortizes them as an adjustment of yield over the term of the real estate-related note receivable. The related accretion of discounts and/or amortization of premiums and origination costs are recorded in real estate-related notes receivables interest income in the accompanying condensed consolidated statements of comprehensive income. Real estate-related notes receivables interest income for the three months ended March 31, 2015 and 2014 was $139,000 and $1,151,000, respectively. As of March 31, 2015, the Company had fixed rate notes receivables with interest rates ranging from 8.0% to 12.0% per annum and a weighted average interest rate of 8.2% per annum.
	Real estate-related notes receivables consisted of the following as of March 31, 2015 and December 31, 2014 (amounts in thousands):
				Outstanding Balance as of
	Real Estate-Related Notes Receivables	Interest Rate	Maturity Date	31-Mar-15		31-Dec-14
	Medistar Loan (1)	8.0%	-2	$	9,500	$	9,500
	MM Peachtree Holdings (3)	12.0%	12/31/21		514		514
	Landmark Loan (4)	9.0%	12/17/15		—		13,521
				$	10,014	$	23,535
	(1)As of March 31, 2015, an affiliate of the Company had an option to purchase the respective property under construction when the construction is completed.
	(2)The Medistar Loan, previously known as the Walnut Hill Bridge Loan, matures upon the earlier to occur of: (i) the sale or refinancing of the property under construction for which proceeds from the loan were used and (ii) April 30, 2015. See Note 17—“Subsequent Events” for a modification of the Medistar Loan.
	(3)Unconsolidated Variable Interest Entity, or VIE. The maximum exposure to loss related to the Company’s variable interest in unconsolidated VIEs is limited to the outstanding balances of the respective real estate-related notes receivables. The Company may be subject to additional losses to the extent of any receivables relating to future funding.
	(4)On January 15, 2015, in connection with the acquisition of the Landmark Hospital of Savannah, located in Savannah, Georgia, the Company applied the outstanding balance to reduce the cash paid at acquisition.
	The Company evaluates the collectability of both interest and principal on each real estate-related note receivable to determine whether it is collectible, primarily through the evaluation of the credit quality indicators, such as underlying collateral and payment history. The Company does not intend to sell its investments in real estate-related notes receivables and it is not likely that the Company will be required to sell its investments in real estate-related notes receivables before recovery of their amortized costs basis, which may be at maturity. No impairment losses were recorded related to investments in real estate-related notes receivables for the three months ended March 31, 2015 and 2014. In addition, no allowances for uncollectability were recorded related to investments in real estate-related notes receivables as of March 31, 2015 and December 31, 2014.

Future_Minimum_Rent

Future Minimum Rent	3 Months Ended
	Mar. 31, 2015
Future Minimum Rent [Abstract]
Future Minimum Rent	Note 7—Future Minimum Rent
	The Company’s real estate assets are leased to tenants under operating leases with varying terms. The leases frequently have provisions to extend the lease agreement. The Company retains substantially all of the risks and benefits of ownership of the real estate assets leased to tenants.
	The future minimum rental income from the Company’s investment in real estate assets under non-cancelable operating leases for the nine months ending December 31, 2015 and for each of the next four years ending December 31 and thereafter, are as follows (amounts in thousands):
	Year	Amount
	Nine months ending December 31, 2015	$	125,291
	2016		168,968
	2017		171,724
	2018		175,024
	2019		178,288
	Thereafter		1,685,131
		$	2,504,426

Notes_Payable_and_Unsecured_Cr

Notes Payable and Unsecured Credit Facility	3 Months Ended
	Mar. 31, 2015
Notes Payable and Unsecured Credit Facility [Abstract]
Notes Payable and Unsecured Credit Facility	Note 8—Notes Payable and Unsecured Credit Facility
	The Company’s debt outstanding as of March 31, 2015 and December 31, 2014 consisted of the following (amounts in thousands):
			31-Mar-15		31-Dec-14
	Notes payable:
	Fixed rate notes payable		$	133,505	$	134,271
	Variable rate notes payable fixed through interest rate swaps			241,603		206,162
	Variable rate notes payable			150,094		150,476
	Total notes payable			525,202		490,909
	Unsecured credit facility:
	Revolving line of credit			150,000		—
	Term loan			75,000		75,000
	Total unsecured credit facility			225,000		75,000
	Total debt outstanding		$	750,202	$	565,909
	Significant loan activity since December 31, 2014, excluding scheduled principal payments, includes:
		·		The Company exercised its option to draw an additional $37,000,000 under a certain note payable with a variable interest rate at the 30-day London interbank offered rate, plus 225 basis points with a maturity date of February 26, 2019, or the Loan. Coincident with the Loan, the Company entered into an interest rate swap agreement to effectively fix the variable interest rate on the Loan at 3.7% per annum.
		·		The Company made a draw of $150,000,000 on its revolving line of credit.
		·		As of March 31, 2015, the total unencumbered pool availability under the credit facility was $365,000,000 and the aggregate unencumbered pool availability was $140,000,000.
		·		As of March 31, 2015, the Company had 6 variable rate notes payable that were fixed through interest rate swaps.
	The principal payments and balloon payments due on the notes payable and the unsecured credit facility for the nine months ending December 31, 2015 and for each of the next four years ending December 31 and thereafter, are as follows (amounts in thousands):
	Year		Principal Payments		Balloon Payments (1)		Total Amount
	Nine months ending December 31, 2015		$	8,135	$	—	$	8,135
	2016			10,859		13,442		24,301
	2017			10,231		330,024		340,255
	2018			8,202		120,364		128,566
	2019			3,548		194,235		197,783
	Thereafter			2,540		48,622		51,162
			$	43,515	$	706,687	$	750,202
	(1)Includes unsecured credit facility.

Intangible_Lease_Liabilities_N

Intangible Lease Liabilities, Net	3 Months Ended
	Mar. 31, 2015
Intangible Lease Liabilities, Net [Abstract]
Intangible Lease Liabilities, Net	Note 9—Intangible Lease Liabilities, Net
	Intangible lease liabilities, net, consisted of the following as of March 31, 2015 and December 31, 2014 (amounts in thousands, except weighted average life amounts):
		31-Mar-15		31-Dec-14
	Below-market leases, net of accumulated amortization of $12,514 and $10,721, respectively (with a weighted average remaining life of 17.5 years and 17.5 years, respectively)	$	53,613	$	55,406
	Ground leasehold liabilities, net of accumulated amortization of $84 and $53, respectively (with a weighted average remaining life of 43.9 years and 44.1 years, respectively)		5,241		5,272
		$	58,854	$	60,678
	The aggregate weighted average remaining life of intangible lease liabilities was 19.8 years as of March 31, 2015 and December 31, 2014.

Commitments_and_Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2015
Commitments and Contingencies [Abstract]
Commitments and Contingencies	Note 10—Commitments and Contingencies
	Litigation
	In the ordinary course of business, the Company may become subject to litigation or claims. As of March 31, 2015, there were, and currently there are, no material pending legal proceedings to which the Company is a party.

RelatedParty_Transactions_and_

Related-Party Transactions and Arrangements	3 Months Ended
	Mar. 31, 2015
Related-Party Transactions and Arrangements [Abstract]
Related-Party Transactions and Arrangements	Note 11—Related-Party Transactions and Arrangements
	The Company pays to the Advisor 2.0% of the contract purchase price of each property or asset acquired and 2.0% of the amount advanced with respect to a mortgage loan. For the three months ended March 31, 2015 and 2014, the Company incurred $2,419,000 and $2,882,000, respectively, in acquisition fees to the Advisor or its affiliates related to investments in real estate. During the three months ended March 31, 2015 and 2014, the Company paid $5,000 and $82,000, respectively, to the Advisor or its affiliates related to investments in real estate-related notes receivables.
	The Company pays the Advisor an annual asset management fee of 0.85% of the aggregate asset value plus costs and expenses incurred by the Advisor in providing asset management services. The fee is payable monthly in an amount equal to 0.07083% of the aggregate asset value as of the last day of the immediately preceding month. For the three months ended March 31, 2015 and 2014, the Advisor recognized $4,033,000 and $2,366,000, respectively, in gross asset management fees. For the three months ended March 31, 2015 and 2014, the Company paid to the Advisor $3,936,000 and $102,000, respectively, in asset management fees.
	The Company reimburses the Advisor for all expenses it paid or incurred in connection with the services provided to the Company, subject to certain limitations. The Company will not reimburse the Advisor for personnel costs in connection with services for which the Advisor receives an acquisition and advisory fee or a disposition fee. For the three months ended March 31, 2015 and 2014, the Advisor allocated $275,000 and $435,000, respectively, in operating expenses on the Company’s behalf. For the three months ended March 31, 2015 and 2014, the Company reimbursed $267,000 and $468,000, respectively, in operating expenses to the Advisor.
	The Company has no direct employees. The employees of the Advisor and other affiliates provide services to the Company related to acquisitions, property management, asset management, accounting, investor relations, and all other administrative services. If the Advisor or its affiliates provides a substantial amount of services, as determined by a majority of the Company’s independent directors, in connection with the sale of one or more properties, the Company will pay the Advisor a disposition fee up to the lesser of 1.0% of the contract sales price and one-half of the brokerage commission paid if a third party broker is involved. In no event will the combined real estate commission paid to the Advisor, its affiliates and unaffiliated third parties exceed 6.0% of the contract sales price. In addition, after investors have received a return on their net capital contributions and an 8.0% cumulative non-compounded annual return, then the Advisor is entitled to receive 15.0% of the remaining net sale proceeds. For the three months ended March 31, 2015 and 2014, the Company did not incur a disposition fee or a subordinated sale fee to the Advisor or its affiliates.
	Upon listing of the Company’s common stock on a national securities exchange, a listing fee equal to 15.0% of the amount by which the market value of the Company’s outstanding stock plus all distributions paid by the Company prior to listing exceeds the sum of the total amount of capital raised from investors and the amount of cash flow necessary to generate an 8.0% cumulative, non-compounded annual return to investors will be paid to the Advisor. For the three months ended March 31, 2015 and 2014, the Company did not incur a listing fee.
	The Company pays Carter Validus Real Estate Management Services, LLC, or the Property Manager, leasing and management fees for the Company’s properties. Such fees equal 3.0% of gross revenues from single-tenant properties and 4.0% of gross revenues from multi-tenant properties. The Company will reimburse the Property Manager and its affiliates for property-level expenses that any of them pay or incur on the Company’s behalf, including salaries, bonuses and benefits of persons employed by the Property Manager and its affiliates, except for the salaries, bonuses and benefits of persons who also serve as one of the Company’s executive officers. The Property Manager and its affiliates may subcontract the performance of their duties to third parties and pay all or a portion of the property management fee to the third parties with whom they contract for these services. If the Company contracts directly with third parties for such services at customary market fees, the Company may pay the Property Manager an oversight fee equal to 1.0% of the gross revenues of the property managed. In no event will the Company pay the Property Manager, the Advisor or its affiliates both a property management fee and an oversight fee with respect to any particular property. The Company will pay the Property Manager a separate fee for the one-time initial rent-up, lease renewals or leasing-up of newly constructed properties in an amount not to exceed the fee customarily charged in arm’s length transactions by others rendering similar services in the same geographic area for similar properties as determined by a survey of brokers and agents in such area. For the three months ended March 31, 2015 and 2014, the Company incurred $1,167,000 and $642,000, respectively, in property management fees to the Property Manager. For the three months ended March 31, 2015 and 2014, the Company paid $1,173,000 and $572,000, respectively, in property management fees to the Property Manager.
	Accounts Payable Due to Affiliates
	The following amounts were outstanding due to affiliates as of March 31, 2015 and December 31, 2014  (amounts in thousands):
	Entity	Fee	31-Mar-15		31-Dec-14
	Carter/Validus Advisors, LLC and its affiliates	Acquisition costs	$	3	$	2
	Carter/Validus Advisors, LLC and its affiliates	Asset management fees		1,404		1,307
	Carter Validus Real Estate Management Services, LLC	Property management fees		379		385
	Carter/Validus Advisors, LLC and its affiliates	General and administrative costs		108		134
	Carter/Validus Advisors, LLC and its affiliates	Loan advisory fees		—		5
			$	1,894	$	1,833

Segment_Reporting

Segment Reporting	3 Months Ended
	Mar. 31, 2015
Segment Reporting [Abstract]
Segment Reporting	Note 12—Segment Reporting
	Management reviews the performance of individual properties and aggregates individual properties based on operating criteria into two reportable segments, and makes operating decisions based on these two reportable segments. The Company’s commercial real estate investments in data centers and healthcare are based on certain underwriting assumptions and operating criteria, which are different for data centers and healthcare. There were no intersegment sales or transfers during the three months ended March 31, 2015 and 2014.
	The Company evaluates performance based on net operating income of the individual properties in each segment. Net operating income, a non-GAAP financial measure, is defined as total revenues, less rental expenses, which excludes depreciation and amortization, general and administrative expenses, acquisition related expenses, asset management fees, interest expense and interest income. The Company believes that segment net operating income serves as a useful supplement to net income because it allows investors and management to measure unlevered property-level operating results and to compare operating results to the operating results of other real estate companies and between periods on a consistent basis. Segment net operating income should not be considered as an alternative to net income determined in accordance with GAAP as an indicator of financial performance, and accordingly, the Company believes that in order to facilitate a clear understanding of the consolidated historical operating results, segment net operating income should be examined in conjunction with net income as presented in the accompanying condensed consolidated financial statements and data included elsewhere in this Quarterly Report on Form 10-Q.
	Real estate-related notes receivables interest income, general and administrative expenses, change in fair value of contingent consideration, acquisition related expenses, asset management fees, depreciation and amortization, other income and interest expense are not allocated to individual segments for purposes of assessing segment performance.
	Non-segment assets primarily consist of corporate assets, including cash and cash equivalents, real estate and escrow deposits, deferred financing costs, real estate-related notes receivables, the Preferred Equity Investment and other assets not attributable to individual properties.
	Summary information for the reportable segments during the three months ended March 31, 2015 and 2014,  are as follows (amounts in thousands):
			Data					Three Months Ended
			Centers			Healthcare		31-Mar-15
	Revenue:
	Rental, parking and tenant reimbursement revenue		$	29,113		$	22,270	$	51,383
	Expenses:
	Rental and parking expenses			-5,060			-2,524		-7,584
	Segment net operating income		$	24,053		$	19,746		43,799
	Revenue:
	Real estate-related notes receivables interest income								139
	Expenses:
	General and administrative expenses								-1,409
	Change in fair value of contingent consideration								-150
	Acquisition related expenses								-3,145
	Asset management fees								-4,033
	Depreciation and amortization								-15,783
	Income from operations								19,418
	Other income (expense):
	Other income								516
	Interest expense								-6,306
	Net income							$	13,628
			Data					Three Months Ended
			Centers			Healthcare		31-Mar-14
	Revenue:
	Rental, parking and tenant reimbursement revenue		$	16,025		$	10,127	$	26,152
	Expenses:
	Rental and parking expenses			-3,106			-635		-3,741
	Segment net operating income		$	12,919		$	9,492		22,411
	Revenue:
	Real estate-related notes receivables interest income								1,151
	Expenses:
	General and administrative expenses								-922
	Acquisition related expenses								-1,225
	Asset management fees								-2,366
	Depreciation and amortization								-8,267
	Income from operations								10,782
	Other income (expense):
	Other income								38
	Interest expense								-4,189
	Net income							$	6,631
	Assets by reportable segments as of March 31, 2015 and December 31, 2014 are as follows (amounts in thousands):
		31-Mar-15			31-Dec-14
	Assets by segment:
	Data centers	$	1,120,817		$	1,130,131
	Healthcare		1,064,067			933,257
	All other		178,166			127,454
	Total assets	$	2,363,050		$	2,190,842
	Capital additions and acquisitions by reportable segments for the three months ended March 31, 2015 and 2014 are as follows (amounts in thousands):
		Three Months Ended
		March 31,
		2015			2014
	Capital additions and acquisitions by segment:
	Data centers	$	50		$	19,513
	Healthcare		120,069			103,721
	Total capital additions and acquisitions	$	120,119		$	123,234

Preferred_Equity_Investment

Preferred Equity Investment	3 Months Ended
	Mar. 31, 2015
Preferred Equity Investment [Abstract]
Preferred Equity Investment	Note 13—Preferred Equity Investment
	On March 11, 2015, the Company invested an aggregate amount of $101,637,000 in the Preferred Equity Investment. The Preferred Equity Investment is stated at cost and consisted of a principal amount of $100,000,000, plus origination costs of $2,262,000, offset by commitment fees of $625,000. During the three months ended March 31, 2015, the Company recognized dividend income related to the Preferred Equity Investment of approximately $438,000.

Fair_Value

Fair Value	3 Months Ended
	Mar. 31, 2015
Fair Value [Abstract]
Fair Value	Note 14—Fair Value
	Real estate-related notes receivables— The estimated fair value of the real estate-related notes receivables was $10,014,000 and $23,421,000 as of March 31, 2015 and December 31, 2014, respectively, as compared to the carrying value of $10,014,000 and $23,535,000 as of March 31, 2015 and December 31, 2014, respectively. The fair value of the Company’s real estate-related notes receivables is estimated using significant unobservable inputs not based on market activity, but rather through particular valuation techniques (Level 3). The fair value was measured based on the income approach valuation methodology, which requires certain judgments to be made by management.
	Preferred Equity Investment—  The carrying value of the Preferred Equity Investment was $101,637,000 as of March 31, 2015, which approximated its fair value.
	Notes payable – Fixed Rate— The estimated fair value of notes payable –  fixed rate measured using quoted prices and observable inputs from similar liabilities (Level 2) was approximately $135,387,000 and $134,837,000 as of March 31, 2015 and December 31, 2014, respectively, as compared to the carrying value of $133,505,000 and $134,271,000 as of March 31, 2015 and December 31, 2014, respectively.
	Notes payable – Variable— The estimated fair value of notes payable – variable rate fixed through interest rate swap agreements (Level 2) was approximately $239,301,000 and $208,889,000 as of March 31, 2015 and December 31, 2014, respectively, as compared to the carrying value of $241,603,000 and $206,162,000 as of March 31, 2015 and December 31, 2014, respectively. The carrying value of the notes payable – variable was $150,094,000 and $150,476,000 as of March 31, 2015 and December 31, 2014, respectively, which approximated its fair value.
	KeyBank Credit Facility—  The carrying value of the KeyBank Credit Facility – variable was $170,000,000 and $20,000,000, which approximated its fair value, as of March 31, 2015 and December 31, 2014, respectively. The estimated fair value of the KeyBank Credit Facility – variable rate fixed through interest rate swap agreements (Level 2) was approximately $51,154,000 and $50,505,000 as of March 31, 2015 and December 31, 2014, respectively, as compared to the carrying value of $55,000,000 and $55,000,000 as of March 31, 2015 and December 31, 2014, respectively.
	Contingent consideration— The Company has contingent obligations to transfer cash payments to the former owner in conjunction with a certain acquisition if specified future operational objectives are met over future reporting periods. Liabilities for contingent consideration will be measured at fair value each reporting period, with the acquisition-date fair value included as part of the consideration transferred, and subsequent changes in fair value recorded in earnings as change in fair value of contingent consideration.
	The estimated fair value and the carrying value of the contingent consideration was $6,720,000 and $6,570,000 as of March 31, 2015 and December 31, 2014, respectively, which is reported in the accompanying condensed consolidated balance sheets in accounts payable and other liabilities. The Company uses an income approach to value the contingent consideration liability, which is determined based on the present value of probability-weighted future cash flows. The Company has classified the contingent consideration liability as Level 3 of the fair value hierarchy due to the lack of relevant observable market data over fair value inputs such as probability-weighting for payment outcomes. Increases in the assessed likelihood of a high payout under a contingent consideration arrangement contributes to increases in the fair value of the related liability. Conversely, decreases in the assessed likelihood of a higher payout under a contingent consideration arrangement contributes to decreases in the fair value of the related liability. Changes in assumptions could have an impact on the payout of contingent consideration arrangements with a maximum payout of $6,720,000 in cash and a minimum payout of $0 as of March 31, 2015.
	Derivative instruments— Considerable judgment is necessary to develop estimated fair values of financial instruments. Accordingly, the estimates presented herein are not necessarily indicative of the amount the Company could realize, or be liable for, on disposition of the financial instruments. The Company has determined that the majority of the inputs used to value its interest rate swaps fall within Level 2 of the fair value hierarchy. The credit valuation adjustment associated with these instruments utilize Level 3 inputs, such as estimates of current credit spreads, to evaluate the likelihood of default by the Company and the respective counterparty. However, as of March 31, 2015, the Company has assessed the significance of the impact of the credit valuation adjustments on the overall valuation of its derivative positions, and has determined that the credit valuation adjustments are not significant to the overall valuation of its interest rate swaps. As a result, the Company determined that its interest rate swaps valuation in its entirety is classified in Level 2 of the fair value hierarchy.
	In accordance with the fair value hierarchy described above, the following table shows the fair value of the Company’s financial assets and liabilities that are required to be measured at fair value on a recurring basis as of March 31, 2015 and December 31, 2014 (amounts in thousands):
		31-Mar-15
		Fair Value Hierarchy
		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total Fair Value
	Assets:
	Derivative assets	$	—	$	47	$	—	$	47
	Total assets at fair value	$	—	$	47	$	—	$	47
	Liabilities:
	Derivative liabilities	$	—	$	-3,794	$	—	$	-3,794
	Contingent consideration obligations		—		—		-6,720		-6,720
	Total liabilities at fair value	$	—	$	-3,794	$	-6,720	$	-10,514
		31-Dec-14
		Fair Value Hierarchy
		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total Fair Value
	Assets:
	Derivative assets	$	—	$	273	$	—	$	273
	Total assets at fair value	$	—	$	273	$	—	$	273
	Liabilities:
	Derivative liabilities	$	—	$	-1,808	$	—	$	-1,808
	Contingent consideration obligations		—		—		-6,570		-6,570
	Total liabilities at fair value	$	—	$	-1,808	$	-6,570	$	-8,378
	The following table provides a roll-forward of the fair value of recurring Level 3 fair value measurements for the three months ended March 31, 2015 and 2014 (amounts in thousands):
		Three Months Ended
		March 31,
		2015		2014
	Liabilities:
	Contingent consideration obligations:
	Beginning balance	$	6,570	$	—
	Additions to contingent consideration obligations		—		—
	Total changes in fair value included in earnings		150		—
	Ending balance	$	6,720	$	—
	Unrealized (gains) losses still held (1)	$	150	$	—
	(1)Represents the unrealized losses or gains recorded in earnings or other comprehensive loss during the period for liabilities classified as Level 3 that are still held at the end of the period.

Derivative_Instruments_and_Hed

Derivative Instruments and Hedging Activities	3 Months Ended
	Mar. 31, 2015
Derivative Instruments and Hedging Activities [Abstract]
Derivative Instruments and Hedging Activities
	Note 15—Derivative Instruments and Hedging Activities
	Cash Flow Hedges of Interest Rate Risk
	The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable rate amounts from a counterparty in exchange for the Company making fixed rate payments over the life of the agreements without exchange of the underlying notional amount.
	The effective portion of changes in the fair value of derivatives designated, and that qualify, as cash flow hedges is recorded in accumulated other comprehensive loss in the accompanying condensed consolidated statement of stockholders’ equity and is subsequently reclassified into earnings in the period that the hedged forecasted transaction affects earnings. During the three months ended March 31, 2015, such derivatives were used to hedge the variable cash flows associated with variable rate debt. The ineffective portion of changes in fair value of the derivatives is recognized directly in earnings. During the three months ended March 31, 2015 and 2014, no gains or losses were recognized due to ineffectiveness of hedges of interest rate risk.
	Amounts reported in accumulated other comprehensive loss related to derivatives will be reclassified to interest expense as interest payments are made on the Company’s variable-rate debt. During the next twelve months, the Company estimates that an additional $3,913,000 will be reclassified from accumulated other comprehensive loss as an increase to interest expense.
	See Note 14—“Fair Value” for a further discussion of the fair value of the Company’s derivative instruments.
	The following table summarizes the notional amount and fair value of the Company’s derivative instruments (amounts in thousands):
									31-Mar-15									31-Dec-14
	Derivatives		Balance						Outstanding			Fair Value of						Outstanding		Fair Value of
	Designated as		Sheet		Effective		Maturity		Notional									Notional
	Hedging Instruments		Location		Dates		Dates		Amount			Asset (1)			(Liability) (2)			Amount		Asset (3)		(Liability) (4)
	Interest rate		Other assets/Accounts		10/12/2012 to		10/11/2017 to		$	296,603		$	47		$	-3,794		$	261,162	$	273	$	-1,808
	swaps		payable and other		8/3/15		7/11/19
			liabilities
	(1)Of this amount, $47,000 related to controlling interests.
	(2)Of this amount, $(3,180,000) related to controlling interests and $(614,000) related to noncontrolling interests.
	(3)Of this amount, $273,000 related to controlling interests.
	(4)Of this amount, $(1,434,000) related to controlling interests and $(374,000) related to noncontrolling interests.
	The notional amount under the agreements is an indication of the extent of the Company’s involvement in each instrument at the time, but does not represent exposure to credit, interest rate or market risks.
	Accounting for changes in the fair value of a derivative instrument depends on the intended use and designation of the derivative instrument. The Company designated the interest rate swaps as cash flow hedges to hedge the variability of the anticipated cash flows on its variable rate notes payable. The change in fair value of the effective portion of the derivative instrument that is designated as a hedge is recorded in other comprehensive income (loss), or OCI, in the accompanying condensed consolidated statements of comprehensive income.
	The table below summarizes the amount of gains or losses recognized on interest rate derivatives designated as cash flow hedges for the three months ended March 31, 2015 and 2014 (amounts in thousands):
	Derivatives in Cash Flow Hedging Relationships		Amount of Loss Recognized in OCI on Derivatives			Location Of Loss Reclassified From Accumulated Other Comprehensive Loss to Net Income		Amount of Loss Reclassified From Accumulated Other Comprehensive Loss to Net Income
			(Effective Portion)			(Effective Portion)		(Effective Portion)
	Three Months Ended March 31, 2015
	Interest rate swaps		$	-3,090		Interest Expense		$	-878
	Total		$	-3,090				$	-878
	Three Months Ended March 31, 2014
	Interest rate swaps		$	-626		Interest Expense		$	-388
	Total		$	-626				$	-388
	Credit Risk-Related Contingent Features
	The Company has agreements with each of its derivative counterparties that contain cross-default provisions, whereby if the Company defaults on certain of its unsecured indebtedness, then the Company could also be declared in default on its derivative obligations, resulting in an acceleration of payment thereunder.
	In addition, the Company is exposed to credit risk in the event of non-performance by its derivative counterparties. The Company believes it mitigates its credit risk by entering into agreements with credit-worthy counterparties. The Company records credit risk valuation adjustments on its interest rate swaps based on the respective credit quality of the Company and the counterparty. As of March 31, 2015, the fair value of derivatives in a net liability position, including accrued interest but excluding any adjustment for nonperformance risk related to these agreements, was $4,372,000. As of March 31, 2015, there were no termination events or events of default related to the interest rate swaps.
	Tabular Disclosure Offsetting Derivatives
	The Company has elected not to offset derivative positions in its condensed consolidated financial statements. The following table presents the effect on the Company’s financial position had the Company made the election to offset its derivative positions as of March 31, 2015 and December 31, 2014 (amounts in thousands):
	Offsetting of Derivative Assets
											Gross Amounts Not Offset in the Balance Sheet
			Gross Amounts of Recognized Assets			Gross Amounts Offset in the Balance Sheet			Net Amounts of Assets Presented in the Balance Sheet									Net Amount
												Financial Instruments Collateral			Cash Collateral
	31-Mar-15	$	47		$	—		$	47		$	—		$	—		$	47
	31-Dec-14	$	273		$	—		$	273		$	—		$	—		$	273
	Offsetting of Derivative Liabilities
											Gross Amounts Not Offset in the Balance Sheet
			Gross Amounts of Recognized Liabilities			Gross Amounts Offset in the Balance Sheet			Net Amounts of Liabilities Presented in the Balance Sheet									Net Amount
												Financial Instruments Collateral			Cash Collateral
	31-Mar-15	$	3,794		$	—		$	3,794		$	—		$	—		$	3,794
	31-Dec-14	$	1,808		$	—		$	1,808		$	—		$	—		$	1,808
	The Company reports derivatives in the accompanying condensed consolidated balance sheets as other assets and accounts payable and other liabilities.

Accumulated_Other_Comprehensiv

Accumulated Other Comprehensive Loss	3 Months Ended
	Mar. 31, 2015
Accumulated Other Comprehensive Loss [Abstract]
Accumulated Other Comprehensive Loss	Note 16—Accumulated Other Comprehensive Loss
	The following table presents a roll-forward of amounts recognized in accumulated other comprehensive loss, net of noncontrolling interests, by component for the three months ended March 31, 2015 (amounts in thousands):
		Unrealized Loss on Derivative Instruments		Accumulated Other Comprehensive Loss
	Balance as of December 31, 2014	$	-1,161	$	-1,161
	Other comprehensive loss before reclassification		-2,730		-2,730
	Amount of loss reclassified from accumulated other
	comprehensive loss to net income (effective portion)		758		758
	Other comprehensive loss		-1,972		-1,972
	Balance as of March 31, 2015	$	-3,133	$	-3,133
	The following table presents reclassifications out of accumulated other comprehensive loss for the three months ended March 31, 2015 (amounts in thousands):
	Details about Accumulated Other Comprehensive Loss Components	Amounts Reclassified from Accumulated Other Comprehensive Loss to Net Income		Affected Line Items in the Condensed Consolidated Statements of Comprehensive Income
	Interest rate swap contracts	$	878	Interest expense

Subsequent_Events

Subsequent Events	3 Months Ended
	Mar. 31, 2015
Subsequent Events [Abstract]
Subsequent Events	Note 17—Subsequent Events
	Distributions Paid
	On April 1, 2015, the Company paid aggregate distributions of $10,504,000 ($4,793,000 in cash and $5,711,000 in shares of the Company’s common stock issued pursuant to the DRIP Offering), which related to distributions declared for each day in the period from March 1, 2015 through March 31, 2015. On May 1, 2015, the Company paid aggregate distributions of $10,204,000 ($4,781,000 in cash and $5,423,000 in shares of the Company’s common stock issued pursuant to the DRIP Offering), which related to distributions declared for each day in the period from April 1, 2015 through April 30, 2015.
	Distributions Declared
	On May 7, 2015, the board of directors of the Company approved and declared a distribution to the Company’s stockholders of record as of the close of business on each day of the period commencing on June 1, 2015 and ending on August 31, 2015. The distributions will be calculated based on 365 days in the calendar year and equal to $0.001917808 per share of common stock, which will be equal to an annualized distribution rate of 7.0%, assuming a purchase price of $10.00 per share. The distributions declared for each record date in June 2015, July 2015 and August 2015 will be paid in July 2015, August 2015 and September 2015, respectively. The distributions will be payable to stockholders from legally available funds therefor.
	Preferred Equity Investment
	On April 1, 2015, the Company invested an additional $25,500,000 in the Preferred Equity Investment.
	Medistar Loan
	On April 27, 2015, the Company modified the Medistar Loan, or the Medistar Loan Modification, to extend the maturity date to the earlier to occur of: (i) the sale or refinancing of the property under construction for which proceeds from the loan were used and (ii) October 30, 2015. In accordance with the Medistar Loan Modification, if the interest payments due are not received prior to October 30, 2015, an additional amount of interest in the amount of $498,000 will be due and payable, calculated based on 8.0% of the outstanding principal amount of the loan from April 1, 2015 through July 31, 2015 and 10.0% thereafter.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policy)	3 Months Ended
	Mar. 31, 2015
Summary of Significant Accounting Policies [Abstract]
Principles of Consolidation and Basis of Presentation	Principles of Consolidation and Basis of Presentation
	The accompanying condensed consolidated financial statements include the accounts of the Company, the Operating Partnership, all majority-owned subsidiaries and controlled subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates
	The preparation of the financial statements in conformity with GAAP necessarily requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
Concentration of Credit Risk and Significant Leases	Concentration of Credit Risk and Significant Leases
	As of March 31, 2015, the Company had cash on deposit, including restricted cash, in several financial institutions which had deposits in excess of current federally insured levels totaling $86.8 million; however, the Company has not experienced any losses in such accounts. The Company limits its cash investments to financial institutions with high credit standings; therefore, the Company believes it is not exposed to any significant credit risk on its cash deposits. To date, the Company has experienced no loss or lack of access to cash in its accounts. Concentration of credit risk with respect to accounts receivable from tenants is limited.
	As of March 31, 2015, the Company owned real estate investments in 43 MSAs, (including two real estate investments owned through consolidated partnerships), four of which accounted for 10.0% or more of rental revenue. Real estate investments located in the Dallas-Ft. Worth-Arlington, Texas MSA, the Chicago-Naperville-Elgin, Illinois-Indiana-Wisconsin MSA, the Atlanta-Sandy Springs-Roswell, Georgia MSA and the Houston-The Woodlands-Sugar Land, Texas MSA accounted for an aggregate of 14.1%, 12.3%,  10.4% and 10.9%, respectively, of rental revenue for the three months ended March 31, 2015.
	As of March 31, 2015, the Company had two tenants that accounted for 10.0% or more of rental revenue. The leases with AT&T Services, Inc. and the lease with Bay Area Regional Medical Center, LLC accounted for 13.6% and 10.7%, respectively, of rental revenue for the three months ended March 31, 2015.
Share Repurchase Program	Share Repurchase Program
	The Company’s share repurchase program allows for repurchases of shares of the Company’s common stock when certain criteria are met. The share repurchase program provides that all redemptions during any calendar year, including those upon death or a qualifying disability of a stockholder, are limited to those that can be funded with proceeds raised from the DRIP Offering.
	Repurchases of shares of the Company’s common stock are at the sole discretion of the Company’s board of directors. In addition, the Company’s board of directors, at its sole discretion, may amend, suspend, reduce, terminate or otherwise change the share repurchase program upon 30 days prior notice to the Company’s stockholders for any reason it deems appropriate. During the three months ended March 31, 2015, the Company received valid redemption requests related to approximately 133,000 shares of common stock, all of which were redeemed in full for an aggregate purchase price of approximately $1,287,000 (an average of $9.68 per share).  During the three months ended March 31, 2014, the Company received valid redemption requests related to approximately 62,000 shares of common stock, all of which were redeemed in full for an aggregate purchase price of approximately $597,000 (an average of $9.63 per share).
Earnings Per Share	Earnings Per Share
	Basic earnings per share attributable for all periods presented are computed by dividing net income attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period. Shares of non-vested restricted common stock give rise to potentially dilutive shares of common stock. Diluted earnings per share are computed based on the weighted average number of shares outstanding and all potentially dilutive securities. For the three months ended March 31, 2015 and 2014, diluted earnings per share reflect the effect of approximately 17,000 of non-vested shares of restricted common stock that were outstanding as of such period.
Preferred Equity Investment	Preferred Equity Investment
	The Company accounts for its Preferred Equity Investment as an asset under the cost method of accounting, as the Company exercises no influence over the investee. The Company recognizes dividends as other income in the condensed consolidated statements of comprehensive income.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements
	On May 28, 2014, the Financial Accounting Standards Board, or the FASB, issued Accounting Standards Update, or ASU, 2014-09, Revenue from Contracts with Customers, or ASU 2014-09. The objective of ASU 2014-09 is to clarify the principles for recognizing revenue and to develop a common revenue standard for GAAP. The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods and services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. ASU 2014-09 defines a five-step process to achieve this core principle, which may require more judgment and estimates within the revenue recognition process than are required under existing GAAP. The adoption of ASU 2014-09 is effective retrospectively for reporting periods beginning after December 15, 2016. Early adoption of ASU 2014-09 is not permitted. The Company is in the process of evaluating the impact ASU 2014-09 will have on the Company’s condensed consolidated financial statements.
	On February 18, 2015, the FASB issued ASU 2015-02, Consolidation (Topic 810): Amendments to the Consolidation Analysis, or ASU 2015-02, that changes the analysis that a reporting entity must perform to determine whether it should consolidate certain types of legal entities. The amendment affects the following areas: limited partnerships and similar legal entities, evaluating fees paid to a decision maker or a service provider as a variable interest, the effect of fee arrangements on the primary beneficiary determination and certain investment funds. Under the amendment, all reporting entities are within the scope of Subtopic 810-10, Consolidation- Overall, unless a scope exception applies. The presumption that a general partner controls a limited partnership has been eliminated. In addition, fees paid to decision makers that meet certain conditions no longer cause decision makers to consolidate variable interest entities in certain instances. The amendment is effective for public business entities for periods beginning after December 15, 2015. Early adoption of ASU 2015-02 is permitted. The Company is in process of evaluating the impact ASU 2015-02 will have in the Company’s condensed consolidated financial statements.
	On April 7, 2015, the FASB issued ASU 2015-03, Interest- Imputation of Interest, or ASU 2015-03, that intends to simplify the presentation of debt issuance costs. The amendment requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability. The amendment is effective for public business entities for periods beginning after December 15, 2015. The Company is in process of evaluating the impact ASU 2015-03 will have in the Company’s condensed consolidated financial statements.
Reclassifications	Reclassifications
	Certain prior period amounts have been reclassified to conform to the current financial statement presentation, with no effect on the Company’s condensed consolidated financial position or results of operations.

Real_Estate_Investments_Tables

Real Estate Investments (Tables)	3 Months Ended
	Mar. 31, 2015
Real Estate Investments [Abstract]
Schedule of Business Combinations
			Date		Ownership
	Property Description		Acquired		Percentage
	Landmark Hospital of Savannah		1/15/15		100%
	21st Century Oncology Portfolio		3/31/15		100%
Schedule of Allocation of Fair Value of Business Combinations
		Total
	Land	$	9,910
	Buildings and improvements		103,004
	In-place leases		8,054
	Total assets acquired	$	120,968
Schedule of Business Combinations on a Pro Forma Basis
			Three Months Ended
			March 31,
			2015			2014
	Pro forma basis:
	Revenues		$	53,640		$	39,662
	Net income		$	17,623		$	12,346
	Net income attributable to common stockholders		$	16,009		$	11,701
	Net income per common share attributable to common
	stockholders:
	Basic		$	0.09		$	0.08
	Diluted		$	0.09		$	0.08

Acquired_Intangible_Assets_Net1

Acquired Intangible Assets, Net (Tables)	3 Months Ended
	Mar. 31, 2015
Acquired Intangible Assets, Net [Abstract]
Schedule of Acquired Intangible Assets, Net
		31-Mar-15		31-Dec-14
	In-place leases, net of accumulated amortization of $25,564 and $21,105, respectively (with a weighted average remaining life of 14.9 years and 15.1 years, respectively)	$	202,306	$	198,710
	Above-market leases, net of accumulated amortization of $619 and $529, respectively (with a weighted average remaining life of 11.2 years and 11.4 years, respectively)		3,027		3,118
	Ground lease interest, net of accumulated amortization of $144 and $131, respectively (with a weighted average remaining life of 61.0 years and 61.2 years, respectively)		2,670		2,683
		$	208,003	$	204,511

Other_Assets_Tables

Other Assets (Tables)	3 Months Ended
	Mar. 31, 2015
Other Assets [Abstract]
Schedule of Other Assets
		31-Mar-15		31-Dec-14
	Deferred financing costs, net of accumulated amortization of $5,430
	and $4,532, respectively	$	10,299	$	11,172
	Lease commissions, net of accumulated amortization of $70
	and $54, respectively		629		394
	Investments in unconsolidated partnerships		104		106
	Tenant receivable, net of allowances for doubtful accounts of $578
	and $0, respectively		2,619		3,361
	Straight-line rent receivable		31,333		25,566
	Restricted cash held in escrow		13,625		13,382
	Real estate escrow deposits		421		250
	Restricted cash		949		734
	Derivative assets		47		273
	Prepaid and other assets, net of allowances for doubtful accounts of $903
	and $0, respectively		3,318		2,189
		$	63,344	$	57,427

Real_EstateRelated_Notes_Recei1

Real Estate-Related Notes Receivables (Tables)	3 Months Ended
	Mar. 31, 2015
Real Estate-Related Notes Receivables [Abstract]
Schedule of Real Estate-Related Notes Receivables
				Outstanding Balance as of
	Real Estate-Related Notes Receivables	Interest Rate	Maturity Date	31-Mar-15		31-Dec-14
	Medistar Loan (1)	8.0%	-2	$	9,500	$	9,500
	MM Peachtree Holdings (3)	12.0%	12/31/21		514		514
	Landmark Loan (4)	9.0%	12/17/15		—		13,521
				$	10,014	$	23,535
	(1)As of March 31, 2015, an affiliate of the Company had an option to purchase the respective property under construction when the construction is completed.
	(2)The Medistar Loan, previously known as the Walnut Hill Bridge Loan, matures upon the earlier to occur of: (i) the sale or refinancing of the property under construction for which proceeds from the loan were used and (ii) April 30, 2015. See Note 17—“Subsequent Events” for a modification of the Medistar Loan.
	(3)Unconsolidated Variable Interest Entity, or VIE. The maximum exposure to loss related to the Company’s variable interest in unconsolidated VIEs is limited to the outstanding balances of the respective real estate-related notes receivables. The Company may be subject to additional losses to the extent of any receivables relating to future funding.
	(4)On January 15, 2015, in connection with the acquisition of the Landmark Hospital of Savannah, located in Savannah, Georgia, the Company applied the outstanding balance to reduce the cash paid at acquisition.

Future_Minimum_Rent_Tables

Future Minimum Rent (Tables)	3 Months Ended
	Mar. 31, 2015
Future Minimum Rent [Abstract]
Schedule of Future Minimum Rental Income from Non-Cancelable Operating Leases
	Year	Amount
	Nine months ending December 31, 2015	$	125,291
	2016		168,968
	2017		171,724
	2018		175,024
	2019		178,288
	Thereafter		1,685,131
		$	2,504,426

Notes_Payable_and_Unsecured_Cr1

Notes Payable and Unsecured Credit Facility (Tables)	3 Months Ended
	Mar. 31, 2015
Notes Payable and Unsecured Credit Facility [Abstract]
Schedule of Debt
		31-Mar-15		31-Dec-14
	Notes payable:
	Fixed rate notes payable	$	133,505	$	134,271
	Variable rate notes payable fixed through interest rate swaps		241,603		206,162
	Variable rate notes payable		150,094		150,476
	Total notes payable		525,202		490,909
	Unsecured credit facility:
	Revolving line of credit		150,000		—
	Term loan		75,000		75,000
	Total unsecured credit facility		225,000		75,000
	Total debt outstanding	$	750,202	$	565,909
Schedule of Future Principal Payments Due on Debt
	Year	Principal Payments		Balloon Payments (1)		Total Amount
	Nine months ending December 31, 2015	$	8,135	$	—	$	8,135
	2016		10,859		13,442		24,301
	2017		10,231		330,024		340,255
	2018		8,202		120,364		128,566
	2019		3,548		194,235		197,783
	Thereafter		2,540		48,622		51,162
		$	43,515	$	706,687	$	750,202
	(1)Includes unsecured credit facility.

Intangible_Lease_Liabilities_N1

Intangible Lease Liabilities, Net (Tables)	3 Months Ended
	Mar. 31, 2015
Intangible Lease Liabilities, Net [Abstract]
Schedule of Intangible Lease Liabilities, Net
		31-Mar-15		31-Dec-14
	Below-market leases, net of accumulated amortization of $12,514 and $10,721, respectively (with a weighted average remaining life of 17.5 years and 17.5 years, respectively)	$	53,613	$	55,406
	Ground leasehold liabilities, net of accumulated amortization of $84 and $53, respectively (with a weighted average remaining life of 43.9 years and 44.1 years, respectively)		5,241		5,272
		$	58,854	$	60,678

RelatedParty_Transactions_and_1

Related-Party Transactions and Arrangements (Tables)	3 Months Ended
	Mar. 31, 2015
Related-Party Transactions and Arrangements [Abstract]
Schedule of Accounts Payable Due to Affiliates
	Entity	Fee	31-Mar-15		31-Dec-14
	Carter/Validus Advisors, LLC and its affiliates	Acquisition costs	$	3	$	2
	Carter/Validus Advisors, LLC and its affiliates	Asset management fees		1,404		1,307
	Carter Validus Real Estate Management Services, LLC	Property management fees		379		385
	Carter/Validus Advisors, LLC and its affiliates	General and administrative costs		108		134
	Carter/Validus Advisors, LLC and its affiliates	Loan advisory fees		—		5
			$	1,894	$	1,833

Segment_Reporting_Tables

Segment Reporting (Tables)	3 Months Ended
	Mar. 31, 2015
Segment Reporting [Abstract]
Schedule of Information for Reportable Segments
			Data					Three Months Ended
			Centers			Healthcare		31-Mar-15
	Revenue:
	Rental, parking and tenant reimbursement revenue		$	29,113		$	22,270	$	51,383
	Expenses:
	Rental and parking expenses			-5,060			-2,524		-7,584
	Segment net operating income		$	24,053		$	19,746		43,799
	Revenue:
	Real estate-related notes receivables interest income								139
	Expenses:
	General and administrative expenses								-1,409
	Change in fair value of contingent consideration								-150
	Acquisition related expenses								-3,145
	Asset management fees								-4,033
	Depreciation and amortization								-15,783
	Income from operations								19,418
	Other income (expense):
	Other income								516
	Interest expense								-6,306
	Net income							$	13,628
			Data					Three Months Ended
			Centers			Healthcare		31-Mar-14
	Revenue:
	Rental, parking and tenant reimbursement revenue		$	16,025		$	10,127	$	26,152
	Expenses:
	Rental and parking expenses			-3,106			-635		-3,741
	Segment net operating income		$	12,919		$	9,492		22,411
	Revenue:
	Real estate-related notes receivables interest income								1,151
	Expenses:
	General and administrative expenses								-922
	Acquisition related expenses								-1,225
	Asset management fees								-2,366
	Depreciation and amortization								-8,267
	Income from operations								10,782
	Other income (expense):
	Other income								38
	Interest expense								-4,189
	Net income							$	6,631
Schedule of Assets by Reportable Segments
		31-Mar-15			31-Dec-14
	Assets by segment:
	Data centers	$	1,120,817		$	1,130,131
	Healthcare		1,064,067			933,257
	All other		178,166			127,454
	Total assets	$	2,363,050		$	2,190,842
Schedule of Capital Additions and Acquisitions by Reportable Segments
		Three Months Ended
		March 31,
		2015			2014
	Capital additions and acquisitions by segment:
	Data centers	$	50		$	19,513
	Healthcare		120,069			103,721
	Total capital additions and acquisitions	$	120,119		$	123,234

Fair_Value_Tables

Fair Value (Tables)	3 Months Ended
	Mar. 31, 2015
Fair Value [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
		31-Mar-15
		Fair Value Hierarchy
		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total Fair Value
	Assets:
	Derivative assets	$	—	$	47	$	—	$	47
	Total assets at fair value	$	—	$	47	$	—	$	47
	Liabilities:
	Derivative liabilities	$	—	$	-3,794	$	—	$	-3,794
	Contingent consideration obligations		—		—		-6,720		-6,720
	Total liabilities at fair value	$	—	$	-3,794	$	-6,720	$	-10,514
		31-Dec-14
		Fair Value Hierarchy
		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total Fair Value
	Assets:
	Derivative assets	$	—	$	273	$	—	$	273
	Total assets at fair value	$	—	$	273	$	—	$	273
	Liabilities:
	Derivative liabilities	$	—	$	-1,808	$	—	$	-1,808
	Contingent consideration obligations		—		—		-6,570		-6,570
	Total liabilities at fair value	$	—	$	-1,808	$	-6,570	$	-8,378
Schedule of Reconciliation of Fair Value of Recurring Level 3 Fair Value Measurements
		Three Months Ended
		March 31,
		2015		2014
	Liabilities:
	Contingent consideration obligations:
	Beginning balance	$	6,570	$	—
	Additions to contingent consideration obligations		—		—
	Total changes in fair value included in earnings		150		—
	Ending balance	$	6,720	$	—
	Unrealized (gains) losses still held (1)	$	150	$	—
	(1)Represents the unrealized losses or gains recorded in earnings or other comprehensive loss during the period for liabilities classified as Level 3 that are still held at the end of the period.

Derivative_Instruments_and_Hed1

Derivative Instruments and Hedging Activities (Tables)	3 Months Ended
	Mar. 31, 2015
Derivative Instruments and Hedging Activities [Abstract]
Schedule of the Notional Amount and Fair Value of Derivative Instruments
									31-Mar-15									31-Dec-14
	Derivatives		Balance						Outstanding			Fair Value of						Outstanding		Fair Value of
	Designated as		Sheet		Effective		Maturity		Notional									Notional
	Hedging Instruments		Location		Dates		Dates		Amount			Asset (1)			(Liability) (2)			Amount		Asset (3)		(Liability) (4)
	Interest rate		Other assets/Accounts		10/12/2012 to		10/11/2017 to		$	296,603		$	47		$	-3,794		$	261,162	$	273	$	-1,808
	swaps		payable and other		8/3/15		7/11/19
			liabilities
	(1)Of this amount, $47,000 related to controlling interests.
	(2)Of this amount, $(3,180,000) related to controlling interests and $(614,000) related to noncontrolling interests.
	(3)Of this amount, $273,000 related to controlling interests.
	(4)Of this amount, $(1,434,000) related to controlling interests and $(374,000) related to noncontrolling interests.
Schedule of Gains or Losses Recognized on Derivative Instruments
	Derivatives in Cash Flow Hedging Relationships		Amount of Loss Recognized in OCI on Derivatives			Location Of Loss Reclassified From Accumulated Other Comprehensive Loss to Net Income		Amount of Loss Reclassified From Accumulated Other Comprehensive Loss to Net Income
			(Effective Portion)			(Effective Portion)		(Effective Portion)
	Three Months Ended March 31, 2015
	Interest rate swaps		$	-3,090		Interest Expense		$	-878
	Total		$	-3,090				$	-878
	Three Months Ended March 31, 2014
	Interest rate swaps		$	-626		Interest Expense		$	-388
	Total		$	-626				$	-388
Schedule of Offsetting of Derivative Assets
	Offsetting of Derivative Assets
											Gross Amounts Not Offset in the Balance Sheet
			Gross Amounts of Recognized Assets			Gross Amounts Offset in the Balance Sheet			Net Amounts of Assets Presented in the Balance Sheet									Net Amount
												Financial Instruments Collateral			Cash Collateral
	31-Mar-15	$	47		$	—		$	47		$	—		$	—		$	47
	31-Dec-14	$	273		$	—		$	273		$	—		$	—		$	273
Schedule of Offsetting of Derivative Liabilities
	Offsetting of Derivative Liabilities
											Gross Amounts Not Offset in the Balance Sheet
			Gross Amounts of Recognized Liabilities			Gross Amounts Offset in the Balance Sheet			Net Amounts of Liabilities Presented in the Balance Sheet									Net Amount
												Financial Instruments Collateral			Cash Collateral
	31-Mar-15	$	3,794		$	—		$	3,794		$	—		$	—		$	3,794
	31-Dec-14	$	1,808		$	—		$	1,808		$	—		$	—		$	1,808

Accumulated_Other_Comprehensiv1

Accumulated Other Comprehensive Loss (Tables)	3 Months Ended
	Mar. 31, 2015
Accumulated Other Comprehensive Loss [Abstract]
Schedule of Amounts Recognized in Accumulated Other Comprehensive Loss
		Unrealized Loss on Derivative Instruments		Accumulated Other Comprehensive Loss
	Balance as of December 31, 2014	$	-1,161	$	-1,161
	Other comprehensive loss before reclassification		-2,730		-2,730
	Amount of loss reclassified from accumulated other
	comprehensive loss to net income (effective portion)		758		758
	Other comprehensive loss		-1,972		-1,972
	Balance as of March 31, 2015	$	-3,133	$	-3,133
Schedule of Reclassifications Out of Accumulated Other Comprehensive Loss
	Details about Accumulated Other Comprehensive Loss Components	Amounts Reclassified from Accumulated Other Comprehensive Loss to Net Income		Affected Line Items in the Condensed Consolidated Statements of Comprehensive Income
	Interest rate swap contracts	$	878	Interest expense

Organization_and_Business_Oper1

Organization and Business Operations (Details) (USD $)	3 Months Ended	42 Months Ended	52 Months Ended
	Mar. 31, 2015	Jun. 06, 2014	Mar. 31, 2015	Dec. 31, 2014	Dec. 10, 2010	Apr. 14, 2014
	segment
	item
	property
Organization and Business Operations [Line Items]
Number of reportable business segments	2
Number of Company owned real estate investments	48		48
Number of Company owned properties	77		77
Number of metropolitan statistical areas in which Company owns rental property	43		43
Real estate-related notes receivables, principal amount	$10,014,000		$10,014,000
Preferred stock, par value	$0.01		$0.01	$0.01
Preferred equity investment, aggregate amount	101,637,000		101,637,000	0
Redemption of common stock	1,287,000
Consolidated Partnerships [Member]
Organization and Business Operations [Line Items]
Number of Company owned real estate investments	2		2
Initial Public Offering [Member]
Organization and Business Operations [Line Items]
Common stock offering, value authorized					1,746,875,000
Common stock offering, gross proceeds raised		1,716,046,000
DRIP Offering [Member]
Organization and Business Operations [Line Items]
Common stock offering, value authorized						100,000,000
Initial Public Offering and DRIP Offering [Member]
Organization and Business Operations [Line Items]
Common stock offering, gross proceeds raised			1,760,455,000
Common stock offering, shares issued			177,271,000
Redemption of common stock			6,353,000
Offering costs, selling commissions and dealer manager fees			174,626,000
Private Real Estate Corporation [Member] | Series B Redeemable Cumulative Preferred Stock [Member]
Organization and Business Operations [Line Items]
Preferred stock, dividend rate percentage	7.88%
Preferred stock, par value	$0.01		$0.01
Preferred equity investment, aggregate amount	$101,637,000		$101,637,000

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Details) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
	item
	property
Summary of Significant Accounting Policies [Line Items]
Cash on deposit, including restricted cash, in excess of current federally insured levels	$86,800,000
Number of metropolitan statistical areas in which Company owns rental property	43
Number of Company owned real estate investments	48
Period of notice required for changes to share repurchase program	30 days
Repurchase of common stock	1,287,000
Repurchase of common stock, average price per share	$9.68	$9.63
Diluted earnings per share outstanding adjustment, shares	17,000	17,000
Rental Revenue [Member] | Geographic Concentration Risk [Member]
Summary of Significant Accounting Policies [Line Items]
Number of metropolitan statistical areas in which Company owns rental property	4
Rental Revenue [Member] | Customer Concentration Risk [Member]
Summary of Significant Accounting Policies [Line Items]
Number of tenants	2
Dallas-Ft. Worth-Arlington, Texas MSA [Member] | Rental Revenue [Member] | Geographic Concentration Risk [Member]
Summary of Significant Accounting Policies [Line Items]
Concentration risk, percentage	14.10%
Chicago-Naperville-Elgin, Illinois-Indiana-Wisconsin MSA [Member] | Rental Revenue [Member] | Geographic Concentration Risk [Member]
Summary of Significant Accounting Policies [Line Items]
Concentration risk, percentage	12.30%
Atlanta-Sandy Springs-Roswell, Georgia MSA [Member] | Rental Revenue [Member] | Geographic Concentration Risk [Member]
Summary of Significant Accounting Policies [Line Items]
Concentration risk, percentage	10.40%
Houston-The Woodlands-Sugar Land, Texas MSA [Member] | Rental Revenue [Member] | Geographic Concentration Risk [Member]
Summary of Significant Accounting Policies [Line Items]
Concentration risk, percentage	10.90%
AT&T Services, Inc. [Member] | Rental Revenue [Member] | Customer Concentration Risk [Member]
Summary of Significant Accounting Policies [Line Items]
Concentration risk, percentage	13.60%
Bay Area Regional Medical Center, LLC [Member] | Rental Revenue [Member] | Customer Concentration Risk [Member]
Summary of Significant Accounting Policies [Line Items]
Concentration risk, percentage	10.70%
Common Stock [Member]
Summary of Significant Accounting Policies [Line Items]
Repurchase of common stock, shares	132,915	62,000
Repurchase of common stock	1,000
Common Stock Including Additional Paid in Capital [Member]
Summary of Significant Accounting Policies [Line Items]
Repurchase of common stock		$597,000
Consolidated Partnerships [Member]
Summary of Significant Accounting Policies [Line Items]
Number of Company owned real estate investments	2

Real_Estate_Investments_Narrat

Real Estate Investments (Narrative) (Details) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Real Estate Investments [Line Items]
Purchase price	$120,968,000
Real estate-related notes receivables converted to investment in real estate	13,674,000	20,000,000
Cash paid for investments in real estate	107,294,000	123,190,000
Revenues	508,000
Net Loss	2,706,000
Acquisition related expenses	3,145,000	1,225,000
2015 Acquisitions [Member]
Real Estate Investments [Line Items]
Acquisition related expenses	$2,929,000
Maximum [Member]
Real Estate Investments [Line Items]
Acquisition fee and expense reimbursement, as percentage of purchase price of properties	6.00%
Healthcare [Member] | 2015 Acquisitions [Member]
Real Estate Investments [Line Items]
Number of acquisitions	2

Real_Estate_Investments_Schedu

Real Estate Investments (Schedule of Business Combinations) (Details)	3 Months Ended
	Mar. 31, 2015
Landmark Hospital of Savannah [Member]
Real Estate Investments [Line Items]
Date Acquired	15-Jan-15
Ownership Percentage	100.00%
21st Century Oncology Portfolio [Member]
Real Estate Investments [Line Items]
Date Acquired	31-Mar-15
Ownership Percentage	100.00%

Real_Estate_Investments_Schedu1

Real Estate Investments (Schedule of Allocation of Fair Value of Business Combinations) (Details) (USD $)	Mar. 31, 2015
In Thousands, unless otherwise specified
Real Estate Investments [Abstract]
Land	$9,910
Buildings and improvements	103,004
In-place leases	8,054
Total assets acquired	$120,968

Real_Estate_Investments_Schedu2

Real Estate Investments (Schedule of Business Combinations on a Pro Forma Basis) (Details) (USD $)	3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Pro forma basis:
Revenues	$53,640	$39,662
Net income	17,623	12,346
Net income attributable to common stockholders	$16,009	$11,701
Net income per common share attributable to common stockholders:
Basic	$0.09	$0.08
Diluted	$0.09	$0.08

Acquired_Intangible_Assets_Net2

Acquired Intangible Assets, Net (Schedule of Acquired Intangible Assets, Net) (Details) (USD $)	3 Months Ended	12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Acquired Intangible Assets, Net [Line Items]
Acquired intangible asset, net of accumulated amortization	$208,003	$204,511
Acquired intangible asset, accumulated amortization	26,327	21,765
Acquired intangible asset, weighted average remaining life	15 years 6 months	15 years 7 months 6 days
In-place leases [Member]
Acquired Intangible Assets, Net [Line Items]
Acquired intangible asset, net of accumulated amortization	202,306	198,710
Acquired intangible asset, accumulated amortization	25,564	21,105
Acquired intangible asset, weighted average remaining life	14 years 10 months 24 days	15 years 1 month 6 days
Above-market leases [Member]
Acquired Intangible Assets, Net [Line Items]
Acquired intangible asset, net of accumulated amortization	3,027	3,118
Acquired intangible asset, accumulated amortization	619	529
Acquired intangible asset, weighted average remaining life	11 years 2 months 12 days	11 years 4 months 24 days
Ground lease interest [Member]
Acquired Intangible Assets, Net [Line Items]
Acquired intangible asset, net of accumulated amortization	2,670	2,683
Acquired intangible asset, accumulated amortization	$144	$131
Acquired intangible asset, weighted average remaining life	61 years	61 years 2 months 12 days

Other_Assets_Schedule_of_Other

Other Assets (Schedule of Other Assets) (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Other Assets [Abstract]
Deferred financing costs, net of accumulated amortization of $5,430 and $4,532, respectively	$10,299	$11,172
Lease commissions, net of accumulated amortization of $70 and $54, respectively	629	394
Investments in unconsolidated partnerships	104	106
Tenant receivable, net of allowances for doubtful accounts of $578 and $0, respectively	2,619	3,361
Straight-line rent receivable	31,333	25,566
Restricted cash held in escrow	13,625	13,382
Real estate escrow deposits	421	250
Restricted cash	949	734
Derivative assets	47	273
Prepaid and other assets, net of allowances for doubtful accounts of $903 and $0, respectively	3,318	2,189
Total other assets	63,344	57,427
Deferred financing costs, accumulated amortization	5,430	4,532
Lease commissions, accumulated amortization	70	54
Tenant receivable, allowances for doubtful accounts	578	0
Prepaid and other assets, allowances for doubtful accounts	$903	$0

Real_EstateRelated_Notes_Recei2

Real Estate-Related Notes Receivables (Narrative) (Details) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014
	loan
Real Estate-Related Notes Receivables [Line Items]
Number of real estate-related notes receivables	2
Real estate-related notes receivables interest income	$139,000	$1,151,000
Impairment loss recorded on real estate-related notes receivables	0	0
Allowance for uncollectability recorded on real estate-related notes receivables	$0		$0
Minimum [Member]
Real Estate-Related Notes Receivables [Line Items]
Per annum interest rate	8.00%
Maximum [Member]
Real Estate-Related Notes Receivables [Line Items]
Per annum interest rate	12.00%
Weighted Average [Member]
Real Estate-Related Notes Receivables [Line Items]
Per annum interest rate	8.20%

Real_EstateRelated_Notes_Recei3

Real Estate-Related Notes Receivables (Schedule of Real Estate-Related Notes Receivables) (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015		Dec. 31, 2014
Real Estate-Related Notes Receivables [Line Items]
Outstanding balance on real estate-related notes receivables	$10,014		$23,535
Medistar Loan [Member]
Real Estate-Related Notes Receivables [Line Items]
Interest rate	8.00%
Maturity date	30-Apr-15
Outstanding balance on real estate-related notes receivables	9,500	[1],[2]	9,500
Landmark Loan [Member]
Real Estate-Related Notes Receivables [Line Items]
Interest rate	9.00%
Maturity date	17-Dec-15
Outstanding balance on real estate-related notes receivables	0	[3]	13,521
Variable Interest Entity, Not Primary Beneficiary [Member] | MM Peachtree Holdings [Member]
Real Estate-Related Notes Receivables [Line Items]
Interest rate	12.00%
Maturity date	31-Dec-21
Outstanding balance on real estate-related notes receivables	$514	[4]	$514
[1]	As of MarchB 31, 2015, an affiliate of the Company had an option to purchase the respective property under construction when the construction is completed.
[2]	The Medistar Loan, previously known as the Walnut Hill Bridge Loan, matures upon the earlier to occur of: (i) the sale or refinancing of the property under construction for which proceeds from the loan were used and (ii) April 30, 2015. See Note 17bbSubsequent Eventsb for a modification of the Medistar Loan.
[3]	On January 15, 2015, in connection with the acquisition of the Landmark Hospital of Savannah, located in Savannah, Georgia, the Company applied the outstanding balance to reduce the cash paid at acquisition.
[4]	Unconsolidated Variable Interest Entity, or VIE. The maximum exposure to loss related to the Companybs variable interest in unconsolidated VIEs is limited to the outstanding balances of the respective real estate-related notes receivables. The Company may be subject to additional losses to the extent of any receivables relating to future funding.

Future_Minimum_Rent_Schedule_o

Future Minimum Rent (Schedule of Future Minimum Rental Income from Non-Cancelable Operating Leases) (Details) (USD $)	Mar. 31, 2015
In Thousands, unless otherwise specified
Future Minimum Rent [Abstract]
Nine months ending December 31, 2015	$125,291
2016	168,968
2017	171,724
2018	175,024
2019	178,288
Thereafter	1,685,131
Total	$2,504,426

Notes_Payable_and_Unsecured_Cr2

Notes Payable and Unsecured Credit Facility (Narrative) (Details) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Debt Instrument [Line Items]
Proceeds from notes payable	$37,000,000	$91,466,000
Proceeds from credit facility	150,000,000	0
Total unencumbered pool availability	365,000,000
Aggregate unencumbered pool availability	140,000,000
Variable Rate, Subject To Interest Rate Swap [Member]
Debt Instrument [Line Items]
Number of notes payable	6
Variable Rate, Subject To Interest Rate Swap [Member] | Note Payable One [Member]
Debt Instrument [Line Items]
Proceeds from notes payable	37,000,000
Notes payable, variable rate basis	30-day London interbank offered rate
Notes payable, basis spread on variable rate	2.25%
Notes payable, maturity date	26-Feb-19
Notes payable, fixed interest rate through interest rate swap agreement	3.70%
Revolving Line Of Credit [Member]
Debt Instrument [Line Items]
Proceeds from credit facility	$150,000,000

Notes_Payable_and_Unsecured_Cr3

Notes Payable and Unsecured Credit Facility (Schedule of Debt) (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Notes payable:
Notes payable	$525,202,000	$490,909,000
Unsecured credit facility:
Credit facility	225,000,000	75,000,000
Total debt outstanding	750,202,000	565,909,000
Fixed Rate [Member]
Notes payable:
Notes payable	133,505,000	134,271,000
Variable Rate, Subject To Interest Rate Swap [Member]
Notes payable:
Notes payable	241,603,000	206,162,000
Unsecured credit facility:
Credit facility	55,000,000	55,000,000
Variable Rate [Member]
Notes payable:
Notes payable	150,094,000	150,476,000
Unsecured credit facility:
Credit facility	170,000,000	20,000,000
Revolving Line Of Credit [Member]
Unsecured credit facility:
Credit facility	150,000,000	0
Term Loan [Member]
Unsecured credit facility:
Credit facility	$75,000,000	$75,000,000

Notes_Payable_and_Unsecured_Cr4

Notes Payable and Unsecured Credit Facility (Schedule of Future Principal Payments Due on Debt) (Details) (USD $)	Mar. 31, 2015		Dec. 31, 2014
In Thousands, unless otherwise specified
Debt Instrument [Line Items]
Nine months ending December 31, 2015	$8,135
2016	24,301
2017	340,255
2018	128,566
2019	197,783
Thereafter	51,162
Total debt outstanding	750,202		565,909
Principal Payments [Member]
Debt Instrument [Line Items]
Nine months ending December 31, 2015	8,135
2016	10,859
2017	10,231
2018	8,202
2019	3,548
Thereafter	2,540
Total debt outstanding	43,515
Balloon Payments [Member]
Debt Instrument [Line Items]
Nine months ending December 31, 2015	0	[1]
2016	13,442	[1]
2017	330,024	[1]
2018	120,364	[1]
2019	194,235	[1]
Thereafter	48,622	[1]
Total debt outstanding	$706,687	[1]
[1]	Includes unsecured credit facility.

Intangible_Lease_Liabilities_N2

Intangible Lease Liabilities, Net (Schedule of Intangible Lease Liabilities, Net) (Details) (USD $)	3 Months Ended	12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Intangible Lease Liabilities, Net [Abstract]
Below-market leases, net of accumulated amortization of $12,514 and $10,721, respectively (with a weighted average remaining life of 17.5 years and 17.5 years, respectively)	$53,613	$55,406
Ground leasehold liabilities, net of accumulated amortization of $84 and $53, respectively (with a weighted average remaining life of 43.9 years and 44.1 years, respectively)	5,241	5,272
Total intangible lease liabilities, net	58,854	60,678
Below-market leases, accumulated amortization	12,514	10,721
Below-market leases, weighted average remaining life	17 years 6 months	17 years 6 months
Ground leasehold liabilities, accumulated amortization	$84	$53
Ground leasehold liabilities, weighted average remaining life	43 years 10 months 24 days	44 years 1 month 6 days
Intangible lease liabilities, weighted average remaining life	19 years 9 months 18 days	19 years 9 months 18 days

Commitments_and_Contingencies_

Commitments and Contingencies (Details)	Mar. 31, 2015
	claim
Commitments and Contingencies [Abstract]
Number of material pending legal proceedings to which the Company is a party	0

RelatedParty_Transactions_and_2

Related-Party Transactions and Arrangements (Narrative) (Details) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Related Party Transaction [Line Items]
Asset management fees	$4,033,000	$2,366,000
Cumulative non-compounded annual return rate to investors	8.00%
Carter/Validus Advisors, LLC And/Or Its Affiliates [Member]
Related Party Transaction [Line Items]
Acquisition fees paid related to investments in real estate	2,419,000	2,882,000
Acquisition fees paid related to investments in real estate-related notes receivables	5,000	82,000
Minimum number of properties required to be sold to incur brokerage commission	1
Disposition fees incurred	0	0
Subordinated sale fees incurred	0	0
Listing fee percentage	15.00%
Listing fees incurred	0	0
Carter/Validus Advisors, LLC And/Or Its Affiliates [Member] | Maximum [Member]
Related Party Transaction [Line Items]
Disposition fee, as percentage of contract sales price	1.00%
Percentage of brokerage commission paid by Company for properties sold that required a substantial amount of services	50.00%
Maximum brokerage commission paid by Company, as percentage of contract sales price	6.00%
Carter/Validus Advisors, LLC [Member]
Related Party Transaction [Line Items]
Acquisition fee, as percentage of contract purchase price of each property or asset acquired	2.00%
Acquisition fee, as percentage of amount advanced on mortgage loan	2.00%
Annual asset management fee, as percentage of aggregate asset value plus costs and expenses incurred by Advisor	0.85%
Monthly asset management fee, as percentage of aggregate asset value as of the last day of the immediately preceding month	0.07%
Asset management fees	4,033,000	2,366,000
Payments for asset management fees	3,936,000	102,000
Operating expenses allocated to the Company by the advisor	275,000	435,000
Reimbursement of operating expenses allocated to the Company by the advisor	267,000	468,000
Percentage of remaining net sales proceeds Advisor will receive after investors receive return	15.00%
Carter Validus Real Estate Management Services, LLC [Member]
Related Party Transaction [Line Items]
Leasing and management fees, as percentage of gross revenues from single-tenant properties	3.00%
Leasing and management fees, as percentage of gross revenues from multi-tenant properties	4.00%
Oversight fee, as percentage of gross revenues from properties managed	1.00%
Property management fees incurred	1,167,000	642,000
Property management fees paid	$1,173,000	$572,000

Recovered_Sheet1

Related-Party Transactions And Arrangements (Schedule of Accounts Payable Due to Affiliates) (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Related Party Transaction [Line Items]
Accounts payable due to affiliates	$1,894	$1,833
Carter/Validus Advisors, LLC And/Or Its Affiliates [Member] | Acquisition Costs [Member]
Related Party Transaction [Line Items]
Accounts payable due to affiliates	3	2
Carter/Validus Advisors, LLC And/Or Its Affiliates [Member] | Asset Management Fees [Member]
Related Party Transaction [Line Items]
Accounts payable due to affiliates	1,404	1,307
Carter/Validus Advisors, LLC And/Or Its Affiliates [Member] | General And Administrative Costs [Member]
Related Party Transaction [Line Items]
Accounts payable due to affiliates	108	134
Carter/Validus Advisors, LLC And/Or Its Affiliates [Member] | Loan Advisory Fees [Member]
Related Party Transaction [Line Items]
Accounts payable due to affiliates	0	5
Carter Validus Real Estate Management Services, LLC [Member] | Property Management Fees [Member]
Related Party Transaction [Line Items]
Accounts payable due to affiliates	$379	$385

Segment_Reporting_Narrative_De

Segment Reporting (Narrative) (Details) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
	segment
Segment Reporting Information [Line Items]
Number of reportable business segments	2
Revenues	$51,522,000	$27,303,000
Intersegment Elimination [Member]
Segment Reporting Information [Line Items]
Revenues	$0	$0

Segment_Reporting_Schedule_of_

Segment Reporting (Schedule of Information for Reportable Segments) (Details) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Segment Reporting Information [Line Items]
Rental and parking expenses	($7,584,000)	($3,741,000)
Real estate-related notes receivables interest income	139,000	1,151,000
General and administrative expenses	-1,409,000	-922,000
Change in fair value of contingent consideration	-150,000	0
Acquisition related expenses	-3,145,000	-1,225,000
Asset management fees	-4,033,000	-2,366,000
Depreciation and amortization	-15,783,000	-8,267,000
Income from operations	19,418,000	10,782,000
Other income	516,000	38,000
Interest expense	-6,306,000	-4,189,000
Net income	13,628,000	6,631,000
Operating Segments [Member]
Segment Reporting Information [Line Items]
Rental, parking and tenant reimbursement revenue	51,383,000	26,152,000
Rental and parking expenses	-7,584,000	-3,741,000
Income from operations	43,799,000	22,411,000
Operating Segments [Member] | Data Centers [Member]
Segment Reporting Information [Line Items]
Rental, parking and tenant reimbursement revenue	29,113,000	16,025,000
Rental and parking expenses	-5,060,000	-3,106,000
Income from operations	24,053,000	12,919,000
Operating Segments [Member] | Healthcare [Member]
Segment Reporting Information [Line Items]
Rental, parking and tenant reimbursement revenue	22,270,000	10,127,000
Rental and parking expenses	-2,524,000	-635,000
Income from operations	$19,746,000	$9,492,000

Segment_Reporting_Schedule_of_1

Segment Reporting (Schedule of Assets by Reportable Segments) (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Assets by segment [Line Items]
Total assets	$2,363,050	$2,190,842
Operating Segments [Member] | Data Centers [Member]
Assets by segment [Line Items]
Total assets	1,120,817	1,130,131
Operating Segments [Member] | Healthcare [Member]
Assets by segment [Line Items]
Total assets	1,064,067	933,257
All Other [Member]
Assets by segment [Line Items]
Total assets	$178,166	$127,454

Segment_Reporting_Schedule_of_2

Segment Reporting (Schedule of Capital Additions and Acquisitions by Reportable Segments) (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Capital additions and acquisitions by segment [Line Items]
Total capital additions and acquisitions	$120,119	$123,234
Operating Segments [Member] | Data Centers [Member]
Capital additions and acquisitions by segment [Line Items]
Total capital additions and acquisitions	50	19,513
Operating Segments [Member] | Healthcare [Member]
Capital additions and acquisitions by segment [Line Items]
Total capital additions and acquisitions	$120,069	$103,721

Preferred_Equity_Investment_De

Preferred Equity Investment (Details) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Mar. 11, 2015
Preferred Equity Investment [Line Items]
Preferred equity investment, dividend income	$516,000	$38,000
Series B Redeemable Cumulative Preferred Stock [Member] | Private Real Estate Corporation [Member]
Preferred Equity Investment [Line Items]
Preferred equity investment, total			101,637,000
Preferred equity investment, principal amount			100,000,000
Preferred equity investment, origination costs			2,262,000
Preferred equity investment, commitment fees			625,000
Preferred equity investment, dividend income	$438,000

Fair_Value_Narrative_Details

Fair Value (Narrative) (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Fair Value [Line Items]
Real estate-related notes receivables, carrying value	$10,014,000	$23,535,000
Preferred equity investment, carrying value	101,637,000	0
Notes payable, carrying value	525,202,000	490,909,000
Credit facility, carrying value	225,000,000	75,000,000
Contingent consideration obligations, fair value and carrying value	6,720,000	6,570,000
Contingent consideration obligations, maximum payout	6,720,000
Contingent consideration obligations, minimum payout	0
Fixed Rate [Member]
Fair Value [Line Items]
Notes payable, carrying value	133,505,000	134,271,000
Variable Rate, Subject To Interest Rate Swap [Member]
Fair Value [Line Items]
Notes payable, carrying value	241,603,000	206,162,000
Credit facility, carrying value	55,000,000	55,000,000
Variable Rate [Member]
Fair Value [Line Items]
Notes payable, carrying value	150,094,000	150,476,000
Credit facility, carrying value	170,000,000	20,000,000
Significant Other Observable Inputs (Level 2) [Member] | Estimated Fair Value [Member] | Fixed Rate [Member]
Fair Value [Line Items]
Notes payable, fair value disclosure	135,387,000	134,837,000
Significant Other Observable Inputs (Level 2) [Member] | Estimated Fair Value [Member] | Variable Rate, Subject To Interest Rate Swap [Member]
Fair Value [Line Items]
Notes payable, fair value disclosure	239,301,000	208,889,000
Credit facility, fair value disclosure	51,154,000	50,505,000
Significant Unobservable Inputs (Level 3) [Member] | Estimated Fair Value [Member]
Fair Value [Line Items]
Real estate-related notes receivables, fair value disclosure	$10,014,000	$23,421,000

Fair_Value_Schedule_of_Fair_Va

Fair Value (Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis) (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Assets:
Derivative assets	$47,000	$273,000
Liabilities:
Derivative liabilities	-3,794,000	-1,808,000
Contingent consideration obligations	-6,720,000	-6,570,000
Recurring Basis [Member]
Assets:
Derivative assets	47,000	273,000
Total assets at fair value	47,000	273,000
Liabilities:
Derivative liabilities	-3,794,000	-1,808,000
Contingent consideration obligations	-6,720,000	-6,570,000
Total liabilities at fair value	-10,514,000	-8,378,000
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Recurring Basis [Member]
Assets:
Derivative assets	0	0
Total assets at fair value	0	0
Liabilities:
Derivative liabilities	0	0
Contingent consideration obligations	0	0
Total liabilities at fair value	0	0
Significant Other Observable Inputs (Level 2) [Member] | Recurring Basis [Member]
Assets:
Derivative assets	47,000	273,000
Total assets at fair value	47,000	273,000
Liabilities:
Derivative liabilities	-3,794,000	-1,808,000
Contingent consideration obligations	0	0
Total liabilities at fair value	-3,794,000	-1,808,000
Significant Unobservable Inputs (Level 3) [Member] | Recurring Basis [Member]
Assets:
Derivative assets	0	0
Total assets at fair value	0	0
Liabilities:
Derivative liabilities	0	0
Contingent consideration obligations	-6,720,000	-6,570,000
Total liabilities at fair value	($6,720,000)	($6,570,000)

Fair_Value_Schedule_of_Reconci

Fair Value (Schedule of Reconciliation of Fair Value of Recurring Level 3 Fair Value Measurements) (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015		Mar. 31, 2014
Contingent consideration obligations:
Beginning balance	$6,570		$0
Additions to contingent consideration obligations	0		0
Total changes in fair value included in earnings	150		0
Ending balance	6,720		0
Unrealized (gains) losses still held	$150	[1]	$0	[1]
[1]	Represents the unrealized losses or gains recorded in earnings or other comprehensive loss during the period for liabilities classified as Level 3 that are still held at the end of the period.

Derivative_Instruments_and_Hed2

Derivative Instruments and Hedging Activities (Narrative) (Details) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Derivative Instruments and Hedging Activities [Abstract]
Gain (loss) recognized due to ineffectiveness of hedges of interest rate risk	$0	$0
Additional amount expected to be reclassified from AOCI into earnings during next twelve months	3,913,000
Fair value of derivatives in a net liability position	$4,372,000

Derivative_Instruments_and_Hed3

Derivative Instruments and Hedging Activities (Schedule of the Notional Amount and Fair Value of Derivative Instruments) (Details) (USD $)	3 Months Ended
	Mar. 31, 2015		Dec. 31, 2014
Derivatives, Fair Value [Line Items]
Fair Value of Asset	47,000		$273,000
Fair Value of (Liability)	-3,794,000		-1,808,000
Interest Rate Swaps [Member] | Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Outstanding Notional Amount	296,603,000		261,162,000
Other Assets [Member] | Interest Rate Swaps [Member] | Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Fair Value of Asset	47,000	[1]	273,000	[2]
Accounts Payable and Other Liabilities [Member] | Interest Rate Swaps [Member] | Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Fair Value of (Liability)	-3,794,000	[3]	-1,808,000	[4]
Minimum [Member] | Interest Rate Swaps [Member] | Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Effective Dates	12-Oct-12
Maturity Dates	11-Oct-17
Maximum [Member] | Interest Rate Swaps [Member] | Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Effective Dates	3-Aug-15
Maturity Dates	11-Jul-19
Parent [Member]
Derivatives, Fair Value [Line Items]
Fair Value of Asset	47,000		273,000
Fair Value of (Liability)	-3,180,000		-1,434,000
Noncontrolling Interests [Member]
Derivatives, Fair Value [Line Items]
Fair Value of (Liability)	-614,000		($374,000)
[1]	Of this amount, $47,000 related to controlling interests.
[2]	Of this amount, $273,000 related to controlling interests.
[3]	Of this amount, $(3,180,000) related to controlling interests and $(614,000) related to noncontrolling interests.
[4]	Of this amount, $(1,434,000) related to controlling interests and $(374,000) related to noncontrolling interests.

Derivative_Instruments_and_Hed4

Derivative Instruments and Hedging Activities (Schedule of Gains or Losses Recognized on Derivative Instruments) (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Loss Recognized in OCI on Derivatives (Effective Portion)	($3,090)	($626)
Amount of Loss Reclassified From Accumulated Other Comprehensive Loss to Net Income (Effective Portion)	-878	-388
Interest Rate Swaps [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Loss Recognized in OCI on Derivatives (Effective Portion)	-3,090	-626
Interest Rate Swaps [Member] | Interest Expense [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Loss Reclassified From Accumulated Other Comprehensive Loss to Net Income (Effective Portion)	($878)	($388)

Derivative_Instruments_and_Hed5

Derivative Instruments and Hedging Activities (Schedule of Offsetting of Derivative Assets) (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Derivative Instruments and Hedging Activities [Abstract]
Gross Amounts of Recognized Assets	$47	$273
Gross Amounts Offset in the Balance Sheet	0	0
Net Amounts of Assets Presented in the Balance Sheet	47	273
Gross Amounts Not Offset in the Balance Sheet, Financial Instruments Collateral	0	0
Gross Amounts Not Offset in the Balance Sheet, Cash Collateral	0	0
Net Amount	$47	$273

Derivative_Instruments_and_Hed6

Derivative Instruments and Hedging Activities (Schedule of Offsetting of Derivative Liabilities) (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Derivative Instruments and Hedging Activities [Abstract]
Gross Amounts of Recognized Liabilities	$3,794	$1,808
Gross Amounts Offset in the Balance Sheet	0	0
Net Amounts Of Liabilities Presented in the Balance Sheet	3,794	1,808
Gross Amounts Not Offset in the Balance Sheet, Financial Instruments Collateral	0	0
Gross Amounts Not Offset in the Balance Sheet, Cash Collateral	0	0
Net Amount	$3,794	$1,808

Accumulated_Other_Comprehensiv2

Accumulated Other Comprehensive Loss (Schedule of Amounts Recognized in Accumulated Other Comprehensive Loss) (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Accumulated Other Comprehensive Loss [Line Items]
Balance as of December 31, 2014	($1,161)
Other comprehensive loss before reclassification	-2,730
Amount of loss reclassified from accumulated other comprehensive loss to net income (effective portion)	758
Other comprehensive loss attributable to common stockholders	-1,972	-238
Balance as of March 31, 2015	-3,133
Unrealized Loss On Derivative Instruments [Member]
Accumulated Other Comprehensive Loss [Line Items]
Balance as of December 31, 2014	-1,161
Other comprehensive loss before reclassification	-2,730
Amount of loss reclassified from accumulated other comprehensive loss to net income (effective portion)	758
Other comprehensive loss attributable to common stockholders	-1,972
Balance as of March 31, 2015	($3,133)

Accumulated_Other_Comprehensiv3

Accumulated Other Comprehensive Loss (Schedule of Reclassifications Out of Accumulated Other Comprehensive Loss) (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Reclassification Adjustment Out Of Accumulated Other Comprehensive Loss [Line Items]
Interest expense	$6,306	$4,189
Reclassification Out Of Accumulated Other Comprehensive Loss [Member] | Unrealized Loss On Derivative Instruments [Member] | Interest Rate Swaps [Member]
Reclassification Adjustment Out Of Accumulated Other Comprehensive Loss [Line Items]
Interest expense	$878

Subsequent_Events_Details

Subsequent Events (Details) (USD $)	3 Months Ended		0 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Apr. 01, 2015	1-May-15	7-May-15	Apr. 27, 2015
Subsequent Event [Line Items]
Distributions paid in cash	$13,714,000	$6,716,000
Distributions reinvested in shares of common stock pursuant to the DRIP Offering	16,594,000	6,527,000
Distributions declared per common share	$0.17	$0.17
Payments to acquire preferred equity investment	101,637,000	0
Subsequent Event [Member] | Series B Redeemable Cumulative Preferred Stock [Member] | Private Real Estate Corporation [Member]
Subsequent Event [Line Items]
Payments to acquire preferred equity investment			25,500,000
Subsequent Event [Member] | March 1, 2015 To March 31, 2015 [Member]
Subsequent Event [Line Items]
Aggregate distributions			10,504,000
Distributions paid in cash			4,793,000
Distributions reinvested in shares of common stock pursuant to the DRIP Offering			5,711,000
Subsequent Event [Member] | April 1, 2015 To April 30, 2015 [Member]
Subsequent Event [Line Items]
Aggregate distributions				10,204,000
Distributions paid in cash				4,781,000
Distributions reinvested in shares of common stock pursuant to the DRIP Offering				5,423,000
Subsequent Event [Member] | June 1, 2015 To August 31, 2015 [Member]
Subsequent Event [Line Items]
Number of days, distribution calculation					365 days
Distributions declared per common share					$0.00
Annualized distribution rate					7.00%
Assumed purchase price per share					$10
Medistar Loan [Member]
Subsequent Event [Line Items]
Maturity date	30-Apr-15
Per annum interest rate	8.00%
Medistar Loan [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Maturity date						30-Oct-15
Interest due and payable at maturity date						$498,000
Minimum [Member]
Subsequent Event [Line Items]
Per annum interest rate	8.00%
Minimum [Member] | Medistar Loan [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Per annum interest rate						8.00%
Maximum [Member]
Subsequent Event [Line Items]
Per annum interest rate	12.00%
Maximum [Member] | Medistar Loan [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Per annum interest rate						10.00%